<!DOCTYPE html>
<html class="no-js" lang="en" dir="ltr" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/terms/" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:sioc="http://rdfs.org/sioc/ns#" xmlns:sioct="http://rdfs.org/sioc/types#" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:schema="http://schema.org/" xmlns:fb="http://ogp.me/ns/fb#">

<head>
  <!-- Set gtm id codes for various environments. -->

	<!-- Google Tag Manager -->
	<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
	new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
	j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
	'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
	})(window,document,'script','dataLayer','GTM-W3ZV');</script>
	<!-- End Google Tag Manager -->
  <meta charset="utf-8">
    <title>Our reports and publications | Cancer Research UK</title>

  <script charset="UTF-8" src="//cdn.cookielaw.org/scripttemplates/otSDKStub.js" data-domain-script="81232513-709c-4b95-8a41-a4b812c22fdc" async=""></script>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<link rel="shortcut icon" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicon.ico">
<link href="/sites/all/themes/custom/cruk/fonts/cruk-icons/CRUKIcons.woff" rel="preload" as="font" crossorigin="1">
<link href="/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-700.woff2" rel="preload" as="font" crossorigin="1">
<link href="/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-500.woff2" rel="preload" as="font" crossorigin="1">
<link href="/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-500.woff2" rel="preload" as="font" crossorigin="1">
<link href="/sites/all/themes/custom/cruk/fonts/progress/Progress-Regular.woff" rel="preload" as="font" crossorigin="1">
<link href="/sites/all/themes/custom/cruk/fonts/Poppins-Regular.woff2" rel="preload" as="font" crossorigin="1">
<link rel="alternate" href="https://www.cancerresearchuk.org/health-professional/our-reports-and-publications" hreflang="en-gb">
<script>{
    "@context": "https://schema.org",
    "@graph": [
        {
            "@type": "Organization",
            "additionalType": "NGO",
            "@id": "https://www.cancerresearchuk.org",
            "name": "Cancer Research UK",
            "address": {
                "@type": "PostalAddress",
                "streetAddress": "2 Redman Place",
                "addressRegion": "London",
                "postalCode": "E20 1JQ",
                "addressCountry": "UK"
            },
            "telephone": "03001234452",
            "url": "https://www.cancerresearchuk.org/",
            "sameAs": [
                "https://en.wikipedia.org/wiki/Cancer_Research_UK",
                "https://www.youtube.com/cancerresearchuk",
                "https://en-gb.facebook.com/cancerresearchuk",
                "https://twitter.com/CR_UK",
                "https://www.instagram.com/cr_uk",
                "https://www.linkedin.com/company/cancer-research-uk"
            ],
            "image": {
                "@type": "ImageObject",
                "url": "https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/cruk-logo.svg"
            },
            "logo": {
                "@type": "ImageObject",
                "representativeOfPage": "True",
                "url": "https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/cruk-logo.svg"
            }
        }
    ]
}</script>
<meta name="description" content="A collection of papers, reports and publications made by the experts at Cancer Research UK.">
<link rel="canonical" href="https://www.cancerresearchuk.org/health-professional/our-reports-and-publications">
<link rel="shortlink" href="https://www.cancerresearchuk.org/node/255381">
<meta property="og:site_name" content="Cancer Research UK">
<meta property="og:type" content="article">
<meta property="og:title" content="Our reports and publications">
<meta property="og:url" content="https://www.cancerresearchuk.org/health-professional/our-reports-and-publications">
<meta property="og:description" content="A collection of papers, reports and publications made by the experts at Cancer Research UK.">
<meta property="og:updated_time" content="2025-06-02T14:18:48+01:00">
<meta property="og:image" content="https://www.cancerresearchuk.org/sites/default/files/health_professionals_reports_and_publications.png">
<meta name="twitter:card" content="summary">
<meta name="twitter:url" content="https://www.cancerresearchuk.org/health-professional/our-reports-and-publications">
<meta name="twitter:title" content="Our reports and publications">
<meta name="twitter:description" content="A collection of papers, reports and publications made by the experts at Cancer Research UK.">
<meta property="article:published_time" content="2018-03-02T13:44:27+00:00">
<meta property="article:modified_time" content="2025-06-02T14:18:48+01:00">

      <link rel="apple-touch-icon" sizes="57x57" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-57x57.png">
<link rel="apple-touch-icon" sizes="60x60" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-60x60.png">
<link rel="apple-touch-icon" sizes="72x72" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-72x72.png">
<link rel="apple-touch-icon" sizes="76x76" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-76x76.png">
<link rel="apple-touch-icon" sizes="114x114" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-114x114.png">
<link rel="apple-touch-icon" sizes="120x120" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-120x120.png">
<link rel="apple-touch-icon" sizes="144x144" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-144x144.png">
<link rel="apple-touch-icon" sizes="60x60" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-152x152.png">
<link rel="apple-touch-icon" sizes="60x60" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-180x180.png">
<link rel="icon" type="image/png" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicon-32x32.png" sizes="32x32">
<link rel="icon" type="image/png" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicon-194x194.png" sizes="194x194">
<link rel="icon" type="image/png" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicon-32x32.png" sizes="96x96">
<link rel="icon" type="image/png" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/android-chrome-192x192.png" sizes="192x192">
<meta name="theme-color" content="#ffffff">
<link rel="icon" type="image/png" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicon-16x16.png" sizes="16x16">
<link rel="manifest" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/manifest.json">
<link rel="shortcut icon" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicon.ico">
<meta name="msapplication-TileImage" content="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/mstile-144x144.png">
<meta name="msapplication-TileColor" content="#ec008c">
<meta name="msapplication-config" content="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicons/browserconfig.xml">
<meta name="apple-mobile-web-app-title" content="CRUK">
<meta name="application-name" content="CRUK">
  
  <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta http-equiv="cleartype" content="on">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <style>
@import url("https://www.cancerresearchuk.org/modules/system/system.base.css?");
@import url("https://www.cancerresearchuk.org/modules/system/system.menus.css?");
@import url("https://www.cancerresearchuk.org/modules/system/system.messages.css?");
@import url("https://www.cancerresearchuk.org/modules/system/system.theme.css?");
</style>
<style>@font-face{font-family:"MuseoSansRounded-500";font-display:swap;src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-500.eot");src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-500.eot?#iefix") format("embedded-opentype"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-500.woff2") format("woff2"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-500.woff") format("woff"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-500.ttf") format("truetype")}@font-face{font-family:"MuseoSansRounded-700";font-display:swap;src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-700.eot");src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-700.eot?#iefix") format("embedded-opentype"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-700.woff2") format("woff2"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-700.woff") format("woff"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-700.ttf") format("truetype")}@font-face{font-family:"MuseoSans-500";font-display:swap;src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-500.eot");src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-500.eot?#iefix") format("embedded-opentype"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-500.woff2") format("woff2"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-500.woff") format("woff"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-500.ttf") format("truetype")}@font-face{font-family:"MuseoSans-700";font-display:swap;src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-700.eot");src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-700.eot?#iefix") format("embedded-opentype"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-700.woff2") format("woff2"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-700.woff") format("woff"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-700.ttf") format("truetype")}@font-face{font-family:"Progress";font-display:swap;src:url("/sites/all/themes/custom/cruk/fonts/progress/Progress-Regular.woff")}@font-face{font-family:'CRUKIcons';src:url("/sites/all/themes/custom/cruk/fonts/cruk-icons/CRUKIcons.eot");src:url("/sites/all/themes/custom/cruk/fonts/cruk-icons/CRUKIcons.eot#iefix") format("embedded-opentype"),url("/sites/all/themes/custom/cruk/fonts/cruk-icons/CRUKIcons.woff") format("woff"),url("/sites/all/themes/custom/cruk/fonts/cruk-icons/CRUKIcons.ttf") format("truetype"),url("/sites/all/themes/custom/cruk/fonts/cruk-icons/CRUKIcons.svg#CRUKIcons") format("svg");font-weight:normal;font-style:normal}.cr-i{display:inline-block;font:normal normal normal 14px/1 CRUKIcons;font-size:inherit;text-rendering:auto;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;speak:none}.cr-i--chevron-down:before{content:"\e905"}body{font-family:"Arial",sans-serif;font-size:14px;padding:0}.container{max-width:960px}*,*:before,*:after{-moz-box-sizing:border-box;-webkit-box-sizing:border-box;box-sizing:border-box}.inner{width:auto;margin:0}@media screen and (min-width: 981px){.inner{width:940px;margin:0 auto}}@media screen and (max-width: 480px){.wrapper{overflow:visible}}@media screen and (min-width: 981px){.wrapper{overflow:hidden;padding-top:0}}/*! normalize.css v2.1.3 | MIT License | git.io/normalize */article,aside,details,figcaption,figure,footer,header,hgroup,main,nav,section,summary{display:block}audio,canvas,video{display:inline-block}audio:not([controls]){display:none;height:0}[hidden],template{display:none}html{font-family:sans-serif;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}body{margin:0}a{background:transparent}a:focus{outline:thin dotted}a:active,a:hover{outline:0}h1{font-size:2em;margin:0.67em 0}abbr[title]{border-bottom:1px dotted}b,strong{font-weight:bold}dfn{font-style:italic}hr{-moz-box-sizing:content-box;box-sizing:content-box;height:0}mark{background:#ff0;color:#000}code,kbd,pre,samp{font-family:monospace, serif;font-size:1em}pre{white-space:pre-wrap}q{quotes:"\201C" "\201D" "\2018" "\2019"}small{font-size:80%}sub,sup{font-size:75%;line-height:0;position:relative;vertical-align:baseline}sup{top:-0.5em}sub{bottom:-0.25em}img{border:0}svg:not(:root){overflow:hidden}figure{margin:0}fieldset{border:1px solid #c0c0c0;margin:0 2px;padding:0.35em 0.625em 0.75em}legend{border:0;padding:0}button,input,select,textarea{font-family:inherit;font-size:100%;margin:0}button,input{line-height:normal}button,select{text-transform:none}button,html input[type="button"],input[type="reset"],input[type="submit"]{-webkit-appearance:button;cursor:pointer}button[disabled],html input[disabled]{cursor:default}input[type="checkbox"],input[type="radio"]{box-sizing:border-box;padding:0}input[type="search"]{-webkit-appearance:textfield;-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box}input[type="search"]::-webkit-search-cancel-button,input[type="search"]::-webkit-search-decoration{-webkit-appearance:none}button::-moz-focus-inner,input::-moz-focus-inner{border:0;padding:0}textarea{overflow:auto;vertical-align:top}table{border-collapse:collapse;border-spacing:0}.container{width:auto;margin-left:auto;margin-right:auto}html{line-height:1.5}body{background-color:#f5f5f5;color:#333}h1{font-size:28px;line-height:1em}@media screen and (max-width: 640px){h1{font-size:23.996px;line-height:1.08em}}h2{font-size:21px;line-height:1.1em}main>h1{clear:both;margin-top:0;padding:15px 0 20px 10px}h1,h2{margin:0 0 .5em;color:#333}h2 a:link{text-decoration:none}p{margin:0 0 1em}header{overflow:hidden}input,button{white-space:normal}a:link{color:#2E008B}.more{margin-bottom:0;list-style:none}.more a{background:transparent url("/sites/all/themes/custom/cruk/images/pink-arrow.png") no-repeat 0 center;color:#e40085;text-decoration:none;padding-left:15px;font-weight:bold}input[type="submit"]{padding:11px 20px;font-family:"MuseoSansRounded-700","MuseoSans-700","Arial","Helvetica",sans-serif;font-size:16.002px;line-height:1.125em;text-align:center;color:#fff;background-color:#e40085;border:none;-moz-border-radius:3px;-webkit-border-radius:3px;border-radius:3px}.button{text-align:center;margin:.5em auto;display:inline-block}.secondary-button a {padding: 11px 10px;text-decoration: none !important;font-family: "MuseoSansRounded-700","MuseoSans-700","Arial","Helvetica",sans-serif;font-size: 16px;line-height: 21px;text-align: center;color: #e40085;background-color: #ffffff;border: 1px solid #e40085;border-radius: 3px}.button a{padding:11px 20px;text-decoration:none !important;display:block;font-family:"MuseoSansRounded-700","MuseoSans-700","Arial","Helvetica",sans-serif;font-size:16.002px;line-height:1.125em;text-align:center;color:#fff;background-color:#e40085;border:none;-moz-border-radius:3px;-webkit-border-radius:3px;border-radius:3px}.site-slogan{color:#2E008B}.lazyloader-icon{position:absolute;z-index:200}.lazyloader-icon{border:3px solid #E4E4E4;border-radius:50%;border-top:3px solid #00b6ed;width:20px;height:20px;-webkit-animation:spin 2s linear infinite;animation:spin 2s linear infinite;display:block;position:absolute;top:50%;left:50%;margin-left:-10px;margin-top:-10px}.siteinfo{background-color:#fff;display:flex;align-items:center;justify-content:space-between;padding-top:0}.siteinfo a{text-decoration:none}a.mhead-right{text-decoration:none}a.mhead-right:link,a.mhead-right:visited{padding:11px 20px;background-color:#e40085;-moz-border-radius:3px;-webkit-border-radius:3px;border-radius:3px;text-align:center;color:#fff;font-size:16.002px;line-height:1.125em;font-family:"MuseoSansRounded-700","MuseoSans-700","Arial","Helvetica",sans-serif}a.mhead-right:focus,a.mhead-right:hover,a.mhead-right:active{background-color:#F033A3}.site-slogan{font-size:1.7em;line-height:1.4em;font-family:"Progress","Arial","Helvetica",sans-serif;margin-bottom:0;color:#000}.site-slogan>a:hover,.site-slogan>a:visited{text-decoration:none;color:#2E008B}.page-node-64706 .siteinfo .mhead-right{display:none}#breadcrumb{background-color:#f5f5f5}#breadcrumb .breadcrumb{font-size:.833em;display:inline;color:#333}@media screen and (max-width: 480px){#breadcrumb{padding:9px 10px 0}}@media screen and (min-width: 481px) and (max-width: 640px){#breadcrumb{padding:9px 20px 0}}@media screen and (min-width: 641px) and (max-width: 800px){#breadcrumb{padding:9px 45px 0}}@media screen and (min-width: 801px) and (max-width: 980px){#breadcrumb{padding:11px 20px 0}}@media screen and (min-width: 981px){#breadcrumb{padding:13px 20px 0}}.in-maintenance .siteinfo{padding-bottom:10px}.in-maintenance #footer-txt{display:none}#dd-searchform{display:flex}#dd-searchform>input{box-sizing:border-box}#cruk-search{font-size:16px;padding:0 0 0 5px}#cruk-search .search{height:40px;width:145px;-moz-border-radius:4px;-webkit-border-radius:4px;border-radius:4px;border:2px solid #C8C8C8;border-right-width:0;border-top-right-radius:0;border-bottom-right-radius:0;padding:1px 0 0 1em}#cruk-search .search::placeholder{color:#C8C8C8}#cruk-search .searchsubmit{border:2px solid #C8C8C8;-moz-border-radius:4px;-webkit-border-radius:4px;border-radius:4px;border-bottom-left-radius:0;border-top-left-radius:0;border-left-width:0;background-color:#fff;color:#C8C8C8}#cruk-search .search:focus{border-color:#00B6ED;outline-width:0}#cruk-search .search:focus+.searchsubmit{border-color:#00B6ED;color:#2E008B}header{background-color:#fff}.header-region{border-top:1px solid #e3e3e3;border-bottom:1px solid #e3e3e3;background-color:#fafafa}.header-region nav{display:none}.megamenu{display:flex;justify-content:space-between;align-items:center;border:none;padding:0;margin:0;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;font-weight:500;list-style:none}.megamenu p{margin:0}.megamenu .clear-fix{float:none;clear:both;margin:0;padding:0;height:0;font-size:0;line-height:0}.megamenu>li>div{display:none}.mm-item>p{display:flex;height:60px}.mm-item-link:link,.mm-item-link:visited{color:#2E008B;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;font-weight:500;font-size:17px;text-decoration:none;padding:0 5px;line-height:20px;z-index:10;display:flex;align-items:center;border-left:1px solid transparent}.mm-item-link:link+.cr-i,.mm-item-link:visited+.cr-i{color:#A7A8AA;display:flex;align-items:center;border-right:1px solid transparent;padding-right:5px}.mm-item-link:last-child{border-right:1px solid transparent}.mm-item-link-hover:link,.mm-item-link-hover:visited{color:#e40085;padding-right:5px;border-color:#e3e3e3;z-index:1001}.mm-item-link-hover:link+.cr-i,.mm-item-link-hover:visited+.cr-i{color:#e40085;border-color:#e3e3e3}.mm-item.selected p>.mm-item-link.mm-item-link,.mm-item.selected p>.cr-i--chevron-down{color:#e40085}.mm-item-content{background-color:#fafafa;border:1px solid #e3e3e3;height:auto;margin-top:1px;position:absolute;z-index:101}.list-content,.list-content ul{padding:0;list-style:none}.toplevel{color:#2E008B;padding:12px 0 5px 20px;width:187px;float:left}.toplevel>p{font-size:14px;line-height:17px}.toplevel>p a{text-decoration:none;color:#2E008B}.toplevel>ul{height:auto;padding:10px 0 0}.toplevel li{margin-bottom:10px}.level3:link,.level3:visited{color:#333;text-decoration:none;font-size:14px;font-weight:normal;line-height:18px;padding-top:0}.level3:hover{color:#e40085}.cruk-logo img{width:100%;height:auto;display:block}#masthead_table{display:none !important}#mobile-rebrand-wrapper{display:block}@media screen and (min-width: 980px){#masthead_table{display:block !important}#mobile-rebrand-wrapper{margin:0 -16px;display:none}}.skip-link{width:100%}.skip-link .element-focusable:focus{position:absolute !important}#main-content:focus{outline:none !important}#mobile-navbar-container{background-color:#FAFAFA}#mobile-rebrand-wrapper #mobile-navbar-container>ul{margin-top:0;display:flex;justify-content:flex-start;height:50px;border-bottom:1px solid #e3e3e3}#mobile-rebrand-wrapper #mobile-navbar-container>ul li{display:flex;align-items:center}@media screen and (max-width: 800px){#top-page,#cruk-search,.site-slogan{display:none}.cruk-logo{padding-left:45px}.mhead-right{margin-right:45px}.siteinfo{padding-top:17px;padding-bottom:17px}}@media screen and (min-width: 481px) and (max-width: 800px){.site-slogan{display:none}}@media screen and (max-width: 480px){.cruk-logo{flex-basis:40%;padding-left:17px}.mhead-right{margin-right:15px}}@media screen and (min-width: 481px) and (max-width: 640px){.cruk-logo{padding-left:20px;width:140px}.mhead-right{margin-right:20px}}@media screen and (min-width: 800px) and (max-width: 980px){.cruk-logo{margin-left:20px}#cruk-nav{padding-left:20px}.mhead-right{margin-right:20px}#cruk-search{display:none}}@media screen and (min-width: 800px){.siteinfo{margin-top:30px;margin-bottom:17px}}.panel-related-row:before,.panel-related-row:after{content:" ";display:table}.panel-related-row:after{clear:both}.pane-promo,.feed-list,.pane-img-text,.pane-bundle-two-column-multi-alignment{background-color:#fff}.grey-panel{background-color:#e3e3e3}.blue-panel img,.white-panel img,.grey-panel img,.pane-show-hide img,.feed-list img,.pane-promo img,.pane-img-text img,.pane-bundle-two-column-multi-alignment img{width:100%;height:auto}.pane-bundle-donation-pane{display:none;background-repeat:no-repeat;background-size:cover;background-position:center}.pane-bundle-donation-pane.visible{display:block}.pane-bundle-donation-pane fieldset{padding:0;margin:0;border:0}.pane-bundle-donation-pane:after{display:none}.pane-bundle-donation-pane .pane-content{color:#fff;height:320px;margin-bottom:20px;text-align:center}.pane-bundle-donation-pane .pane-content:before{content:"";display:inline-block;height:100%;vertical-align:middle;margin-right:-0.25em}.pane-bundle-donation-pane .pane-content form{height:100%;display:block;padding:1em;position:relative}.pane-bundle-donation-pane .pane-content form>div{height:100%}.pane-bundle-donation-pane .pane-content h2{color:#fff;font-size:1.86em;line-height:1.1em;margin-bottom:.2em;margin-left:auto;margin-right:auto;max-width:260px}@media screen and (min-width: 800px){.pane-bundle-donation-pane .pane-content h2{line-height:1.4em;margin-bottom:.35em;max-width:600px}}.pane-bundle-donation-pane .pane-content .form-radios label{display:inline}.homepage .pane-bundle-donation-pane{background-repeat:no-repeat;border-radius:0;background-color:#2E008B}.homepage .pane-bundle-donation-pane .pane-content:before{display:none}.homepage .pane-bundle-donation-pane .pane-content form{height:100%;display:block;padding:1em;position:relative}@media screen and (min-width: 641px){.homepage .pane-bundle-donation-pane .pane-content form{float:right}}@media screen and (min-width: 801px){.homepage .pane-bundle-donation-pane .pane-content form{width:38%}}.homepage .pane-bundle-donation-pane .pane-content form>div{height:100%}.homepage .pane-bundle-donation-pane .pane-content form>div:before{content:"";display:inline-block;height:100%;vertical-align:middle;margin-right:-0.25em}.homepage .pane-bundle-donation-pane .form-steps{display:inline-block;vertical-align:bottom;margin-bottom:.5em}@media screen and (min-width: 641px){.homepage .pane-bundle-donation-pane .form-steps{vertical-align:middle}}.direct-donation-v2-pane.pane-bundle-donation-pane{display:block;background-position:30%}@media screen and (min-width: 800px){.direct-donation-v2-pane.pane-bundle-donation-pane{background-position:left}}@media screen and (min-width: 640px){.direct-donation-v2-pane.pane-bundle-donation-pane{background-position:15%}}.direct_donation_v2#cruk-donate-donation-pane-form .branding-content{height:100%;width:100%;padding:1em;display:table}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .branding-content{padding-bottom:1em;width:63%}}.direct_donation_v2#cruk-donate-donation-pane-form .branding-content .branding-content-inner{display:table-cell;padding-bottom:0;vertical-align:bottom}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .branding-content .branding-content-inner{padding:0 25% 0 0}}.direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-heading{font-size:22px;line-height:normal;text-shadow:0 0 20px rgba(0,0,0,0.75);width:100%;padding:0 0 .5em;margin-bottom:0;max-width:100%;text-align:center;letter-spacing:.03em}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-heading{font-size:26px;line-height:28px;text-align:left;padding:0 0 7% 5%}}.direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-subheading{display:none}.direct_donation_v2#cruk-donate-donation-pane-form .direct-donation-v2-form{background-color:#fff;border-radius:0;z-index:1;display:block;margin-bottom:20px;padding:2em;position:relative;float:left;width:100%;box-sizing:border-box}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .direct-donation-v2-form{float:none;padding:1em;position:absolute;top:3em;right:6em;max-width:calc(28% - 2em);margin-bottom:0}}@media screen and (max-width: 800px) and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .direct-donation-v2-form{top:2em;right:2em;max-width:calc(33% - 2em)}}@media screen and (min-width: 640px){.homepage .direct_donation_v2#cruk-donate-donation-pane-form .branding-content{padding-bottom:1em;width:67%}}.homepage .direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-heading{padding:0 0 .5em;margin-bottom:0}@media screen and (min-width: 640px){.homepage .direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-heading{font-size:26px;line-height:40px;text-align:left;padding:0 0 0 20%}}.homepage .direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-subheading{display:block;font-size:16px}@media screen and (min-width: 640px){.homepage .direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-subheading{font-size:18px;text-align:left;margin-left:20%}}.homepage .direct_donation_v2#cruk-donate-donation-pane-form .direct-donation-v2-form{margin-bottom:0}@media screen and (min-width: 640px){.homepage .direct_donation_v2#cruk-donate-donation-pane-form .direct-donation-v2-form{right:2em;top:2em}}@media screen and (max-width: 640px){.direct-donation-v2-pane.pane-bundle-donation-pane .pane-content:before{display:none}}.direct_donation_v2#cruk-donate-donation-pane-form{padding:0;width:100%;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;display:block}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form{float:right}}.direct_donation_v2#cruk-donate-donation-pane-form>div:before{display:none}.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type input[name="donation_type"]{position:fixed;opacity:0}.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type div{width:47%;display:inline-block;font-size:20px}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type div{font-size:14px}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type label{background-color:#fff;border:1px solid #2E008B;color:#2E008B;display:block;font-weight:normal;padding:12px}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type label{padding:8px}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type label:hover,.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type label:focus{background-color:#2E008B !important;color:#fff;cursor:pointer}.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type input[name="donation_type"]:checked+label{color:#fff;background-color:#2E008B}.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type{display:flex;justify-content:space-between}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div{display:flex;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;width:100%;color:#2E008B;background-color:#fff;margin-right:5%}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div div:last-child,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div div:last-child{margin-right:0px}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div input,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div input{position:fixed;opacity:0}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div div{width:47%;display:inline-block;font-size:20px}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div div{font-size:14px}}@media screen and (max-width: 638px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div div{padding-top:30px;display:inline-block}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div label,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div label{background-color:#fff;border:2px solid #e3e3e3;color:#2E008B;display:block;font-weight:normal;padding:12px}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div label,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div label{padding:4px 0px 4px 0px}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div label:hover,.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div label:focus,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div label:hover,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div label:focus{background-color:#2E008B !important;color:#fff;cursor:pointer}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div input:checked+label,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div input:checked+label{color:#fff;background-color:#2E008B}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div{padding:9px 0;font-size:inherit}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-single>div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly>div{border:none}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-single>div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly>div{padding:9px 0;font-size:inherit}}.direct_donation_v2#cruk-donate-donation-pane-form .amount-separator{font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;font-size:20px;margin-bottom:5%;color:#2E008B}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .amount-separator{font-size:16px}}@media screen and (max-width: 638px){.direct_donation_v2#cruk-donate-donation-pane-form .amount-separator{padding-top:15px}}.direct_donation_v2#cruk-donate-donation-pane-form .pound-symbol{position:absolute;font-size:20px;margin:13px 0 0 12px;color:#2E008B;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .pound-symbol{font-size:18px;margin:8px 0 0 12px}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-amount-other{width:100%;padding:14px 10px 14px 35px;font-size:20px;color:#2E008B;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;border:2px solid #e3e3e3}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-amount-other{padding:10px 10px 10px 35px;font-size:15px}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-amount-other:focus{border-color:#e40085;outline:0}.direct_donation_v2#cruk-donate-donation-pane-form #edit-amount-other::placeholder{font-size:20px;color:#C8C9C7;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-amount-other::placeholder{font-size:15px}}.direct_donation_v2#cruk-donate-donation-pane-form .input-other-amnt-wrapper{float:none;display:block;position:relative}.direct_donation_v2#cruk-donate-donation-pane-form .submit-btn{width:100%;height:50px;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;font-size:20px;color:#fff;background:#e40085;margin:10% 0 0 0;padding:0}.direct_donation_v2#cruk-donate-donation-pane-form .submit-btn:hover{background:#F033A3}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .submit-btn{font-size:16px;height:42px}}fieldset{-moz-border-radius:3px;-webkit-border-radius:3px;border-radius:3px;border:1px solid #e3e3e3;background-color:#fff;margin:0 0 20px 0;padding:15px 20px 20px;clear:both}
/*# sourceMappingURL=critical.css.map */
</style>
<style>
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/ui/themes/base/minified/jquery.ui.core.min.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/ui/themes/base/minified/jquery.ui.theme.min.css?");
</style>
<style>
@import url("https://www.cancerresearchuk.org/modules/aggregator/aggregator.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_gc_timeline/css/grand_challenge_timeline.css?");
@import url("https://www.cancerresearchuk.org/modules/field/theme/field.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/geofield_gmap/geofield_gmap.css?");
@import url("https://www.cancerresearchuk.org/modules/node/node.css?");
@import url("https://www.cancerresearchuk.org/modules/search/search.css?");
@import url("https://www.cancerresearchuk.org/modules/user/user.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/extlink/css/extlink.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/views/css/views.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/ckeditor/css/ckeditor.css?");
</style>
<style>
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/ctools/css/ctools.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/panels/css/panels.css?");
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/layouts/100_333_73_landing_wide_multi_panels/100_333_73_landing_wide_multi_panels.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_donate/selectmenu/jquery.ui.selectmenu.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/node_embed/plugins/node_embed/node_embed.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_taxonomy_glossary/css/cruk_taxonomy_glossary.css?");
</style>
<style>
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/css/tabs_to_accordion.css?");
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/css/style.css?");
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/css/cruk.menus.css?");
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/css/mobile.menu.css?");
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/css/slick.css?");
</style>
<style media="print">
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/css/print.css?");
</style>
<style>
@import url("https://www.cancerresearchuk.org/sites/default/files/ctools/css/d8941fb35cec075cfcb80998f82e95c3.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_31.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_131.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_156.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_196.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_201.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_206.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_211.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_226.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_241.css?");
</style>
<link rel="stylesheet" href="https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_251.css?" media="screen">
<style>
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_261.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_276.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_281.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_291.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_296.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_306.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_361.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_371.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_376.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_426.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_441.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_456.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_466.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_471.css?");
</style>
<style media="screen">
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_516.css?");
</style>
<link rel="stylesheet" href="https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_561.css?">
<style>
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_576.css?");
</style>
<link rel="stylesheet" href="https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_581.css?">
<link rel="stylesheet" href="https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_610.css?">
<style>
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_616.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_617.css?");
</style>
<link rel="stylesheet" href="https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_619.css?">
<style>
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_620.css?");
</style>
  <script>
    window.CancerResearchUK = {};
  </script>
    <!--[if lt IE 9]>
  <script src="https://www.cancerresearchuk.org/sites/all/themes/contrib/mothership/mothership/js/respond.min.js"></script>
  <script src="https://www.cancerresearchuk.org/sites/all/themes/contrib/mothership/mothership/js/html5.js"></script>
  <![endif]-->

  </head>

<body class="not-front no-sidebars page-node page-node- page-node-255381 node-type-cancer-information-standard-page">

<!-- The gtm id code variable ($gtm_code) is set in gtm-header.inc.php -->

  <!-- Google Tag Manager (noscript) -->
  <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-W3ZV" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
  <!-- End Google Tag Manager (noscript) -->

<div id="top-page">
  <div class="inner">
    <div class="skip-link"><a href="#main-content" class="element-invisible element-focusable">Skip to main content</a></div>
  </div>
</div>


<header role="banner">
  <div class="siteinfo inner">
          <div class="cruk-logo">
        <a href="/" title="Cancer Research UK Homepage" rel="home">
          <img src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk_integrated_campaign/logo.svg" width="222" height="86" alt="Cancer Research UK Homepage">
        </a>
      </div>
    
          <p class="site-slogan">Together we are beating cancer</p>
    
    
    <div id="cruk-search">
      <form action="https://find.cancerresearchuk.org/" id="dd-searchform">
        <input type="hidden" value="1" name="siteid">
        <input type="text" class="search" placeholder="Search" name="q" id="q">
        <button aria-label="Search" name="searchsubmit" id="searchsubmit" class="searchsubmit">
          <span class="cr-i cr-i--search"></span>
        </button>
      </form>
    </div>



    <a class="mhead-right" href="/get-involved/donate/">Donate</a>
  </div><!-- #siteinfo -->

  <div class="header-region">
    <div class="inner">
            <!-- start: ul megamenu -->
      <div>
    <div id="cruk-nav">
      <div id="masthead_table">
        <ul class="megamenu" id="drupal-mdd"><li class="mm-item"><p><a href="/about-cancer/" class="mm-item-link">About cancer</a><span class="cr-i cr-i--chevron-down"></span></p>
      <div style="width: 940px">
          <ul class="list-content" id="about-cancer-menu"><li class="toplevel"><p><a href="/about-cancer/type" class="level2">Cancer types</a></p><ul><li><a href="/about-cancer/breast-cancer" class="level3">Breast cancer</a></li><li><a href="/about-cancer/bowel-cancer" class="level3">Bowel cancer</a></li><li><a href="/about-cancer/lung-cancer" class="level3">Lung cancer</a></li><li><a href="/about-cancer/prostate-cancer" class="level3">Prostate cancer</a></li></ul></li><li class="toplevel"><p><a href="/about-cancer/cancer-in-general" class="level2">Cancers in general</a></p><ul><li><a href="/about-cancer/cancer-symptoms" class="level3">Symptoms</a></li><li><a href="/about-cancer/screening" class="level3">Screening</a></li><li><a href="/about-cancer/tests-and-scans" class="level3">Tests</a></li><li><a href="/about-cancer/treatment" class="level3">Treatment</a></li><li><a href="/about-cancer/find-a-clinical-trial" class="level3">Clinical trials</a></li></ul></li><li class="toplevel"><p><a href="/about-cancer/causes-of-cancer" class="level2">Causes of cancer</a></p><ul><li><a href="/about-cancer/causes-of-cancer/smoking-and-cancer" class="level3">Smoking</a></li><li><a href="/about-cancer/causes-of-cancer/alcohol-and-cancer" class="level3">Alcohol</a></li><li><a href="/about-cancer/causes-of-cancer/diet-and-cancer" class="level3">Diet</a></li><li><a href="/about-cancer/causes-of-cancer/bodyweight-and-cancer" class="level3">Obesity</a></li><li><a href="/about-cancer/causes-of-cancer/sun-uv-and-cancer" class="level3">Sun and UV</a></li></ul></li><li class="toplevel"><p><a href="/about-cancer/coping-with-cancer" class="level2">Coping with cancer</a></p><ul><li><a href="/about-cancer/coping-with-cancer/coping-physically/" class="level3">Managing symptoms and side effects</a></li><li><a href="/about-cancer/coping/mental-health-cancer" class="level3">Mental health and cancer</a></li><li><a href="/about-cancer/coping-with-cancer/coping-practically/" class="level3">Money and travel</a></li><li><a href="/about-cancer/coping-with-cancer/dying/" class="level3">Death and dying</a></li><li><a href="https://cancerchat.cancerresearchuk.org/" class="level3">Cancer Chat forum</a></li></ul></li><li class="toplevel"><p><a href="/health-professional" class="level2">Health Professionals</a></p><ul><li><a href="/health-professional/cancer-statistics" class="level3">Cancer Statistics</a></li><li><a href="/health-professional/screening" class="level3">Cancer Screening</a></li><li><a href="/health-professional/learning-and-support" class="level3">Learning and Support</a></li><li><a href="/health-professional/learning-and-development-tools/nice-cancer-referral-guidelines" class="level3">NICE suspected cancer referral guidelines</a></li></ul></li></ul>
      </div>
    </li><li class="mm-item"><p><a href="/get-involved" class="mm-item-link">Get involved</a><span class="cr-i cr-i--chevron-down"></span></p>
      <div style="width: 940px">
          <ul class="list-content" id="get-involved-menu"><li class="toplevel"><p><a href="/get-involved/donate" class="level2">Donate</a></p><ul><li><a href="/get-involved/donate" class="level3">Make a donation</a></li><li><a href="/get-involved/leave-a-legacy-gift-in-your-will" class="level3">Leave a legacy gift</a></li><li><a href="/get-involved/donate/donate-in-memory" class="level3">Donate in memory</a></li><li><a href="/get-involved/donate/philanthropy" class="level3">Philanthropy</a></li><li><a href="/node/143661" class="level3">Weekly Lottery</a></li></ul></li><li class="toplevel"><p><a href="/get-involved/find-an-event" class="level2">Find an event</a></p><ul><li><a href="https://raceforlife.cancerresearchuk.org/" class="level3">Race for Life</a></li><li><a href="/get-involved/find-an-event/charity-runs" class="level3">Charity runs</a></li><li><a href="/get-involved/find-an-event/charity-walks-treks-and-hikes" class="level3">Charity walks</a></li><li><a href="https://find.cancerresearchuk.org/events?size=n_20_n&amp;sort-field=startDate&amp;sort-direction=asc" class="level3">Search events</a></li><li><a href="http://relay.cancerresearchuk.org" class="level3">Relay For Life</a></li></ul></li><li class="toplevel"><p><a href="/get-involved/volunteer" class="level2">Volunteer</a></p><ul><li><a href="/get-involved/volunteer/volunteer-in-our-shops" class="level3">Volunteer in our shops</a></li><li><a href="/get-involved/volunteer/help-at-an-event" class="level3">Help at an event</a></li><li><a href="/get-involved/volunteer/help-us-raise-money" class="level3">Help us raise money</a></li><li><a href="/how-to-cancer-campaign" class="level3">Campaign for us</a></li></ul></li><li class="toplevel"><p><a href="/get-involved/do-your-own-fundraising" class="level2">Do your own fundraising</a></p><ul><li><a href="/get-involved/do-your-own-fundraising/fundraising-ideas" class="level3">Fundraising ideas</a></li><li><a href="/get-involved/do-your-own-fundraising/get-fundraising-pack" class="level3">Get a fundraising pack</a></li><li><a href="/get-involved/do-your-own-fundraising/return-your-money" class="level3">Return fundraising money</a></li><li><a href="/get-involved/do-your-own-fundraising/target-your-fundraising" class="level3">Fundraise by cancer type</a></li><li><a href="/get-involved/do-your-own-fundraising/practical-fundraising-help/set-up-a-cancer-research-uk-giving-page" class="level3">Set up a Cancer Research UK Giving Page</a></li></ul></li><li class="toplevel"><p>More...</p><ul><li><a href="/get-involved/find-a-shop" class="level3">Find a shop or superstore</a></li><li><a href="/get-involved/become-a-partner" class="level3">Become a partner</a></li><li><a href="/get-involved/donate/kids-and-teens" class="level3">Cancer Research UK for Children &amp; Young People</a></li><li><a href="/get-involved/we-are" class="level3">Our We Are campaign</a></li></ul></li></ul>
      </div>
    </li><li class="mm-item"><p><a href="/our-research" class="mm-item-link">Our research</a><span class="cr-i cr-i--chevron-down"></span></p>
      <div style="width: 940px">
          <ul class="list-content" id="our-research-menu"><li class="toplevel"><p><a href="/our-research/our-research-by-cancer-type" class="level2">By cancer type</a></p><ul><li><a href="/node/198836" class="level3">Brain tumours</a></li><li><a href="/node/199166" class="level3">Skin cancer</a></li><li><a href="/node/196346/" class="level3">Breast cancer</a></li><li><a href="/our-research/our-research-by-cancer-type" class="level3">All cancer types</a></li></ul></li><li class="toplevel"><p><a href="/our-progress" class="level2">Our achievements timeline</a></p><ul></ul></li><li class="toplevel"><p><a href="/our-research/our-research-by-cancer-subject" class="level2">By cancer topic</a></p><ul><li><a href="/node/206811" class="level3">New treatments</a></li><li><a href="/our-research/our-research-by-cancer-subject/our-research-on-cancer-biology" class="level3">Cancer biology</a></li><li><a href="/node/206651" class="level3">Cancer drugs</a></li><li><a href="/our-research/our-research-by-cancer-subject" class="level3">All cancer subjects</a></li></ul></li><li class="toplevel"><p><a href="/funding-for-researchers/our-research-strategy" class="level2">Our research strategy</a></p><ul></ul></li><li class="toplevel"><p><a href="/our-research/involving-animals-in-research" class="level2">Involving animals in research</a></p><ul></ul></li></ul>
      </div>
    </li><li class="mm-item"><p><a href="/funding-for-researchers" class="mm-item-link">Funding for researchers</a><span class="cr-i cr-i--chevron-down"></span></p>
      <div style="width: 940px">
          <ul class="list-content" id="funding-for-researchers-menu"><li class="toplevel"><p><a href="/funding-for-researchers" class="level2">Research opportunities</a></p><ul><li><a href="/funding-for-researchers/research-opportunities-in-basic-science-and-discovery-research" class="level3">For discovery researchers</a></li><li><a href="/funding-for-researchers/clinical-research" class="level3">For clinical researchers</a></li><li><a href="/funding-for-researchers/research-opportunities-in-population-and-behavioural-research" class="level3">For population researchers</a></li><li><a href="/funding-for-researchers/drug-discovery-and-development" class="level3">In drug discovery &amp; development</a></li><li><a href="/funding-for-researchers/research-opportunities-in-early-detection-and-diagnosis" class="level3">In early detection &amp; diagnosis</a></li><li><a href="/funding-for-researchers/develop-your-research-career" class="level3">Develop your research career</a></li></ul></li><li class="toplevel"><p><a href="/funding-for-researchers/our-funding-schemes?items_per_page=40" class="level2">Our funding schemes</a></p><ul><li><a href="/funding-for-researchers/our-funding-schemes/career-development-fellowship" class="level3">Career Development Fellowship</a></li><li><a href="/funding-for-researchers/our-funding-schemes/discovery-programme-awards" class="level3">Discovery Programme Awards</a></li><li><a href="/funding-for-researchers/our-funding-schemes/clinical-research-funding-scheme" class="level3">Clinical Research Funding Scheme</a></li><li><a href="/funding-for-researchers/our-funding-schemes/biology-to-prevention-award" class="level3">Biology to Prevention Award</a></li><li><a href="/funding-for-researchers/our-funding-schemes" class="level3">View all schemes and deadlines</a></li></ul></li><li class="toplevel"><p><a href="/funding-for-researchers/applying-for-funding" class="level2">Applying for funding</a></p><ul><li><a href="/funding-for-researchers/applying-for-funding/start-your-funding-application-online" class="level3">Start your application online</a></li><li><a href="/funding-for-researchers/applying-for-funding/how-to-make-a-successful-application" class="level3">How to make a successful application</a></li><li><a href="/funding-for-researchers/applying-for-funding/funding-committees" class="level3">Funding committees</a></li><li><a href="/funding-for-researchers/applying-for-funding/how-to-make-a-successful-application/successful-applicant-case-studies" class="level3">Successful applicant case studies</a></li></ul></li><li class="toplevel"><p><a href="/funding-for-researchers/how-we-deliver-research" class="level2">How we deliver research</a></p><ul><li><a href="/funding-for-researchers/our-research-strategy" class="level3">Our research strategy</a></li><li><a href="/funding-for-researchers/our-research-infrastructure" class="level3">Our research infrastructure</a></li><li><a href="/funding-for-researchers/research-events-and-conferences" class="level3">Events and conferences</a></li><li><a href="/funding-for-researchers/how-we-deliver-research/our-research-partnerships" class="level3">Our research partnerships</a></li><li><a href="/funding-for-researchers/facts-and-figures-about-our-research-funding" class="level3">Facts &amp; figures about our funding</a></li></ul></li><li class="toplevel"><p>More...</p><ul><li><a href="/funding-for-researchers/patient-involvement-toolkit-for-researchers" class="level3">Patient involvement toolkit for researchers</a></li><li><a href="/funding-for-researchers/how-we-deliver-research/recently-funded-awards" class="level3">Recently funded awards</a></li><li><a href="/funding-for-researchers/manage-your-research-grant" class="level3">Manage your research grant</a></li><li><a href="/home/funding-for-researchers/manage-your-research-grant/tell-us-about-new-publications" class="level3">Notify us of new publications</a></li></ul></li></ul>
      </div>
    </li><li class="mm-item"><p><a href="/get-involved/ways-to-shop" class="mm-item-link">Shop</a><span class="cr-i cr-i--chevron-down"></span></p>
      <div style="width: 940px">
          <ul class="list-content" id="shop-menu"><li class="toplevel"><p><a href="/get-involved/find-a-shop" class="level2">Find a shop</a></p><ul><li><a href="/get-involved/volunteer/volunteer-in-our-shops" class="level3">Volunteer in a shop</a></li><li><a href="/get-involved/donate/donate-goods" class="level3">Donate goods to a shop</a></li><li><a href="/get-involved/ways-to-shop/superstores" class="level3">Our superstores</a></li></ul></li><li class="toplevel"><p><a href="https://shop.cancerresearchuk.org/" class="level2">Shop online</a></p><ul><li><a href="https://shop.cancerresearchuk.org/pages/race-for-life" class="level3">Race for Life</a></li><li><a href="https://shop.cancerresearchuk.org/products/wedding-favours" class="level3">Wedding favours</a></li><li><a href="https://shop.cancerresearchuk.org/cancer-care" class="level3">Cancer Care</a></li><li><a href="https://flowershop.cancerresearchuk.org/" class="level3">Flower Shop</a></li></ul></li><li class="toplevel"><p><a href="https://www.ebay.co.uk/str/ukcancerresearch" class="level2">Our eBay store</a></p><ul><li><a href="https://www.ebay.co.uk/str/ukcancerresearch/Dresses/_i.html?_storecat=13763243016" class="level3">Dresses</a></li><li><a href="https://www.ebay.co.uk/str/ukcancerresearch/Shoes-and-Boots/_i.html?_storecat=13763242016" class="level3">Shoes and boots</a></li><li><a href="https://www.ebay.co.uk/str/ukcancerresearch/Bags-Purses/_i.html?_storecat=13869673016" class="level3">Bags and purses</a></li></ul></li></ul>
      </div>
    </li><li class="mm-item"><p><a href="/about-us/" class="mm-item-link">About us</a><span class="cr-i cr-i--chevron-down"></span></p>
      <div style="width: 940px">
          <ul class="list-content" id="about-us-menu"><li class="toplevel"><p><a href="/about-us" class="level2">What we do</a></p><ul><li><a href="/our-research" class="level3">We beat cancer</a></li><li><a href="/get-involved/how-your-support-helps" class="level3">We fundraise</a></li><li><a href="/about-us/we-develop-policy" class="level3">We develop policy</a></li><li><a href="/global-role" class="level3">Our global role</a></li></ul></li><li class="toplevel"><p><a href="/about-us/our-organisation" class="level2">Our organisation</a></p><ul><li><a href="/about-us/our-organisation/beating-cancer-sooner-our-strategy" class="level3">Our strategy</a></li><li><a href="/about-us/how-we-are-run/our-trustees" class="level3">Our Trustees</a></li><li><a href="/about-us/how-we-are-run/chief-executive-and-executive-board" class="level3">CEO and Executive Board</a></li><li><a href="/about-us/our-organisation/how-we-spend-your-money" class="level3">How we spend your money</a></li></ul></li><li class="toplevel"><p><a href="/about-us/careers" class="level2">Careers</a></p><ul><li><a href="/about-us/careers/early-in-career-opportunities" class="level3">Early careers</a></li><li><a href="/about-us/careers/teams" class="level3">Our teams</a></li><li><a href="/about-us/careers/benefits" class="level3">Benefits</a></li></ul></li><li class="toplevel"><p><a href="https://news.cancerresearchuk.org/" class="level2">Cancer news</a></p><ul><li><a href="https://news.cancerresearchuk.org/" class="level3">Cancer News</a></li><li><a href="https://news.cancerresearchuk.org/for-researchers/" class="level3">For Researchers</a></li><li><a href="https://news.cancerresearchuk.org/for-supporters/" class="level3">For Supporters</a></li></ul></li><li class="toplevel"><p>More...</p><ul><li><a href="/about-us/contact-us" class="level3">Contact us</a></li><li><a href="/about-us/press-office" class="level3">Press office</a></li><li><a href="https://publications.cancerresearchuk.org" class="level3">Publications</a></li><li><a href="/about-us/contact-us/opt-in-form" class="level3">Update your contact preferences</a></li></ul></li></ul>
      </div>
    </li></ul>
      </div>
    </div>
  </div>
      <noscript>
        <ul class="megamenu js-off">
          <!-- start: top li -->
          <li class="mm-item"><p><a class="mm-item-link" href="/about-cancer">ABOUT CANCER</a></p></li>
          <!-- end: top li -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- start: top li -->
          <li class="mm-item"><p><a class="mm-item-link" href="/get-involved">GET INVOLVED</a></p></li>
          <!-- end: top li -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- start: top li -->
          <li class="mm-item"><p><a class="mm-item-link" href="/cancer-info">NEWS &amp; RESOURCES</a></p></li>
          <!-- end: top li -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- start: top li -->
          <li class="mm-item"><p><a class="mm-item-link" href="/science">FUNDING &amp; RESEARCH</a></p></li>
          <!-- end: top li -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- start: top li -->
          <li class="mm-item"><p><a class="mm-item-link" href="/about-us">ABOUT US</a></p></li>
          <!-- end: top li -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
        </ul>
      </noscript>
      <!-- end: ul megamenu -->
    </div>
  </div><!-- .header-region -->
  <div id="breadcrumb">
    <div class="inner">
      <p class="element-invisible">You are here</p><div class="breadcrumb"><a href="/">Home</a><img src="/sites/all/themes/custom/cruk/images/breadcrumb-arrow.png" alt=""><a href="/health-professional" class="menu-node-unpublished menu-node-unpublished menu-node-unpublished menu-node-unpublished menu-node-unpublished">Health professional</a><img src="/sites/all/themes/custom/cruk/images/breadcrumb-arrow.png" alt="">Our reports and publications</div>    </div>
  </div>
</header>


<div class="page">
  <div class="wrapper no-gutter container">
    <main role="main" id="main-content" tabindex="-1">
      <!-- start of main content -->
                    <h1>Our reports and publications</h1>
                  
      
      
            
    <div class="wide_100_73_333_multi">

   <div id="panel-row-0" class="panel-row top-section no-gutter col-md-12 col-sm-12 col-xs-12">
                      <div id="panel-1" class="hero-section-mid col-md-8 col-sm-8 col-xs-12">
                   <div class="panel-content">
                    
<div class="panel-pane pane-entity-field pane-node-field-hero">
  
    


<div class="pane-content">
  
<!-- field-image.tpl.php -->
<div class="field field-type-image">
  
  
                <div class="field-item" rel="schema:primaryImageOfPage" resource="https://www.cancerresearchuk.org/sites/default/files/health_professionals_reports_and_publications.png"><img typeof="foaf:Image" src="https://www.cancerresearchuk.org/sites/default/files/health_professionals_reports_and_publications.png" alt="Navy icon of a publication" title="Navy icon of a publication"></div>
      
        </div>
</div>


</div>
                   </div>
              </div>
        
                  <div id="panel-2" class="cta-section col-md-4 col-sm-4 col-xs-12">
               <div class="cta">
                <div class="panel-pane pane-fieldable-panels-pane pane-current-137731 pane-promo blue-panel">
  
        <h2 class="pane-title">Highlights</h2>
    
  
  <div class="pane-content">
    <div class="fieldable-panels-pane">
    

<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"> <div class="more">
<p><a href="/sites/default/files/cruk_2025_economic_losses_due_to_cancer_mortality_technical_brief.pdf?11"><span><span><span>Economic losses due to cancer mortality in the UK</span></span></span></a></p>
</div>
<div class="more"><a href="/health-professional/our-reports-and-publications?123#cancerUK">Cancer in the UK 2025 reports</a></div>
<div class="more"></div>
<div class="more"><a href="/sites/default/files/1-_and_5-year_conditional_survival_for_patients_diagnosed_in_england_2015-2019.pdf?11">1- and 5- year conditional survival</a></div>
<div class="more"></div>
<div class="more"><a href="/sites/default/files/cancer_in_the_uk_2025_socioeconomic_deprivation.pdf?123">Cancer in the UK 2025: Socioeconomic deprivation</a></div>
<div class="more"></div>
<div class="more"><a href="/sites/default/files/projected_uk_cancer_cases_caused_by_tobacco.pdf?11">Projected UK cancer cases caused by tobacco</a></div>
<div class="more"></div>
<div class="more"></div>
 </div>
        </div>
</div>
  </div>

  
  </div>
               </div>
          </div>
           </div>

                      <div id="panel-3" class="col-md-12 col-sm-12 col-xs-12">
                   <div class="panel-content">
                        
<div class="panel-pane pane-fieldable-panels-pane pane-current-56136 pane-bundle-fieldable-panels-pane pane-promo">
  
    


<div class="pane-content">
  <div class="fieldable-panels-pane">
    

<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"> <h2>Explore a selection of reports and publications from the Cancer Intelligence experts at Cancer Research UK, and through various collaborations.</h2>
<p></p>
<table border="0" cellpadding="5" cellspacing="10">
<tr>
<td><a href="#data">Data Hubs</a></td>
<td>
<p><a href="#incidmortsurv">Incidence, mortality and survival</a></p>
</td>
<td><a href="#covid19">Covid-19 and Cancer</a></td>
<td><a href="#treatment">Treatment and post diagnosis</a></td>
<td><a href="#risk">Risk factors and symptom awareness</a></td>
<td><a href="#diagnosis">Diagnosis and Screening</a></td>
<td><a href="#cancerUK">Cancer in the UK</a></td>
<td><a href="#behaviour">Behavioural Science</a></td>
<td><a href="#cancerwaitingtimes">Cancer Waiting Times</a></td>
</tr>
</table>
<p><a id="data" name="data"></a></p>
 </div>
        </div>
</div>
</div>


</div>
                   </div>
              </div>
        

   <div id="panel-row-1" class="panel-row panel-related-row">
        
            </div>

                      <div id="panel-6" class="col-md-12 col-sm-12 col-xs-12">
                <div class="panel-content">
                    
<div class="panel-pane pane-fieldable-panels-pane pane-current-135336 pane-bundle-cruk-info-gallery">
  
      <h2 class="pane-title">
  Data Hubs</h2>



<div class="pane-content">
  <div class="info-gallery info-gallery-id-21" id="info-gallery-id-21"><div class="pane_body"></div><div class="field-items"><div class="info_slide info_slide_76116"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/blue-stats-icon_0.png?itok=_PSFRWaI" alt="Blue Stats Icon "></div><div class="info_title_wrapper"><p class="slide_title info_title">Local Stats Data Hub</p><p class="slide_name"></p></div><div class="slide_body"><p>The local stats data hub gives provides information across the cancer pathway for each constituency area based on publicly available data. It includes information on smoking prevalence, childhood overweight and obesity, bowel screening, cancer waiting times, cancer incidence and cancer mortality.</p>

<div class="more"><a href="https://crukcancerintelligence.shinyapps.io/LocalStats/">Explore our Local Stats Data Hub</a></div>
</div></div><div class="info_slide info_slide_75474"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/navy-stats-icon.png?itok=yMQhLxv6" alt="Stats icon"></div><div class="info_title_wrapper"><p class="slide_title info_title">Cancer Waiting Times and Diagnostic Activity Data Hub</p><p class="slide_name"></p></div><div class="slide_body"><p>The CRUK Cancer Intelligence Teams Cancer Waiting Times and Diagnostic Activity Data Hub gathers the latest data from across the UK on cancer waiting times performance and diagnostic activity and waiting times. You can view breakdowns for some of this information by a specific cancer site and country.</p>

<div class="more"><a href="https://crukcancerintelligence.shinyapps.io/CancerServicesWaitingTimes/">Explore our Cancer Waiting Times and Diagnostic Activity Data Hub</a></div>
</div></div><div class="info_slide info_slide_68416"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/pink-stats-icon.png?itok=rxZrlpYQ" alt="Stats icon"></div><div class="info_title_wrapper"><p class="slide_title info_title">Early Diagnosis Data Hub</p><p class="slide_name"></p></div><div class="slide_body"><p>The CRUK Cancer Intelligence Teams Early Diagnosis Data Hub gathers information and statistics across a number of cancer early diagnosis measures including incidence and survival by stage at diagnosis, screening uptake, urgent GP referrals and routes to diagnosis. You can view breakdowns for some of this information by a specific cancer site and country.</p>

<div class="more"></div>

<div class="more"><a href="https://crukcancerintelligence.shinyapps.io/EarlyDiagnosis/">Explore our Early Diagnosis Data Hub</a></div>
</div></div><div class="info_slide info_slide_68421"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/blue-stats-icon.png?itok=UGjPtUw-" alt="Stats icon"></div><div class="info_title_wrapper"><p class="slide_title info_title">Children and Young Peoples Cancers Data Hub</p><p class="slide_name"></p></div><div class="slide_body"><p>The CRUK Cancer Intelligence Teams Children and Young People Cancer data hub uses data from Public Health England to provide a dashboard for cancer incidence and survival for 024-year-olds in the UK and its constituent nations. You can view data for each country by sex, age, main ICCC-3 diagnostic group and diagnostic subgroups.</p>

<div class="more"><a href="https://crukcancerintelligence.shinyapps.io/CYPCancerData/">Explore our Children and Young Peoples Cancers Data Hub</a></div>
</div></div><div class="info_slide info_slide_78301"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_stats_navy.png?itok=dNw_bpiM" alt="icon stats"></div><div class="info_title_wrapper"><p class="slide_title info_title">Treatment Data Hub</p><p class="slide_name"></p></div><div class="slide_body"><p>The CRUK Cancer Intelligence Teams Treatment Data hub gathers information and statistics across a number of cancer treatment measures, including proportions of treatments given over time and detailed data on radiotherapy delivery. You can also view overviews of many national cancer site audits, split by site and country.</p>

<div class="more"><a href="https://crukcancerintelligence.shinyapps.io/Treatment/">Explore our Treatment Data Hub</a></div>
</div></div></div><div class="info_gallery_nav" id="info_gallery_nav_21"><ol class="info_links equal_height_links"><li id="info_gallery_link_" class="info_link info_gallery_link_76116"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/blue-stats-icon_0.png?itok=_PSFRWaI" alt=""></div><div class="link_bg"><p class="link_title">Local Stats Data Hub</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_75474"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/navy-stats-icon.png?itok=yMQhLxv6" alt=""></div><div class="link_bg"><p class="link_title">Cancer Waiting Times and Diagnostic Activity Data Hub</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_68416"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/pink-stats-icon.png?itok=rxZrlpYQ" alt=""></div><div class="link_bg"><p class="link_title">Early Diagnosis Data Hub</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_68421"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/blue-stats-icon.png?itok=UGjPtUw-" alt=""></div><div class="link_bg"><p class="link_title">Children and Young Peoples Cancers Data Hub</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_78301"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_stats_navy.png?itok=dNw_bpiM" alt=""></div><div class="link_bg"><p class="link_title">Treatment Data Hub</p><p class="link_name"></p></div></a></li></ol></div></div></div>


</div>
                </div>
              </div>
        
    <div id="panel-row-2" class="panel-row panel-related-row">
        
        
            </div>

    <div id="panel-row-3" class="panel-row panel-related-row">
        
        
            </div>

    <div id="panel-row-4" class="panel-row panel-related-row">
        
        
            </div>

    <div id="panel-row-5" class="panel-row panel-related-row">
        
        
            </div>

                     <div id="panel-19" class="panel-box panel-related-box col-md-12 col-sm-12 col-xs-12">
                 <div class="fieldable-panels-pane">
    

<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"> <p><a id="incidmortsurv" name="incidmortsurv"></a></p>
 </div>
        </div>
</div>
<div class="panel-separator"></div>
<div class="panel-pane pane-fieldable-panels-pane pane-uuid-d2fee9c7-20f4-4b7b-8a40-747f980a6090 pane-bundle-cruk-info-gallery">
  
      <h2 class="pane-title">
  Incidence, mortality and survival</h2>



<div class="pane-content">
  <div class="info-gallery info-gallery-id-3" id="info-gallery-id-3"><div class="pane_body"></div><div class="field-items"><div class="info_slide info_slide_78687"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_graph_arrow_economic_benefits_magenta1.png?itok=sCyZtRzp" alt="Magenta icon showing a graph"></div><div class="info_title_wrapper"><p class="slide_title info_title">Economic losses due to cancer mortality in the UK</p><p class="slide_name"></p></div><div class="slide_body"><p><span style="font-size:12pt"><span style="font-family:Aptos,sans-serif"><span style="font-size:11.0pt">Cancer Research UKs analysis uses data on cancer deaths in 2023 coupled with labour market data to estimate productivity loss in the UK from cancer mortality. The study shows that the expected loss in future productivity due to cancer deaths in 2023 is 10.27bn. This lost productivity is the result of 350,000 fewer years expected to be worked, highlighting that cancer has the largest impact on productivity due to premature mortality of any other cause of death. This report provides valuable economic evidence, building on previous work by further estimating this cost by age group, UK nation, and cancer site. This economic evidence is essential to galvanise action by governments to prevent and control cancer, by demonstrating the economic return for this investment.</span></span></span></p>

<div class="more"><a href="/sites/default/files/cruk_2025_economic_losses_due_to_cancer_mortality_technical_brief.pdf?11y_technical_brief.pdf?11"><span style="font-size:11.0pt"><span style='font-family:"Aptos",sans-serif'>Read our full analysis here </span></span></a></div>
</div></div><div class="info_slide info_slide_78314"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/small_-_jpg-icon_survival_cyan1.jpg?itok=Q_A9oMAx" alt="Survival icon in cyan"></div><div class="info_title_wrapper"><p class="slide_title info_title">1- and 5- year conditional survival</p><p class="slide_name"></p></div><div class="slide_body"><p>Our CRUK-NHS England partnership team have calculated conditional 1- and 5- year survival estimates for patients diagnosed in England between 2015 and 2019. This analysis calculates the survival of patients who have already survived their diagnosis for at least 1, 3, 6 or 12 months. Breakdowns are presented for 14cancersites and additionallyby gender, stage, ageand deprivation quintile.</p>

<div class="more"><a href="/sites/default/files/1-_and_5-year_conditional_survival_for_patients_diagnosed_in_england_2015-2019.pdf">Read the 1- and 5- year conditional survival report in full</a></div>
</div></div><div class="info_slide info_slide_78221"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_mortality_navy1.png?itok=AGM2vRHd" alt="Icon showing mortality in navy"></div><div class="info_title_wrapper"><p class="slide_title info_title">Cancer cases and deaths in the current parliamentary term</p><p class="slide_name"></p></div><div class="slide_body"><p>The Cancer Research UK analysis brief examines cancer cases and deaths in the UK during the current parliamentary term. It provides data on trends in cancer incidence and mortality across different demographics, highlighting disparities in cancer outcomes by age, gender, and socioeconomic status. The report underscores the need for targeted interventions to address these disparities and improve survival rates. It also discusses the impact of early detection, treatment advances, and prevention strategies on cancer outcomes. The findings aim to inform policymakers and public health strategies to reduce the burden of cancer in the UK.</p>

<p>Read the full<a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.cancerresearchuk.org%2Fsites%2Fdefault%2Ffiles%2Fanalysis_brief_-_cancer_cases_and_deaths_in_the_current_parliamentary_term_final_sept_2024.pdf%3F11&amp;data=05%7C02%7CRachel.Franklin%40cancer.org.uk%7C313b1d73196e4ca0f7e508dd581ee63d%7C4473892f71e046fc8dec273902b51349%7C0%7C0%7C638763611931036666%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=aofonBCrBbVJRJGb8maZAb3ucZ8VKHYKTxHwg4rS%2B3c%3D&amp;reserved=0" title="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.cancerresearchuk.org%2Fsites%2Fdefault%2Ffiles%2Fanalysis_brief_-_cancer_cases_and_deaths_in_the_current_parliamentary_term_final_sept_2024.pdf%3F11&amp;data=05%7C02%7CRachel.Franklin%40can">Cancer cases and deaths in the current parliamentary term</a>report</p>
</div></div><div class="info_slide info_slide_78222"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_mortality_cyan1.png?itok=-M4fM431" alt="Icon showing mortality in cyan"></div><div class="info_title_wrapper"><p class="slide_title info_title">Mortality by Deprivation Analysis</p><p class="slide_name"></p></div><div class="slide_body"><p>This report examines the relationship between deprivation and cancer mortality in the UK and its constituent countries. All analyses were completed within each country separately and then summed to UK totals. The report finds cancer mortality rates are 55% higher in the most versus the least deprived quintiles in the UK, and a similar deprivation gradient is evident across all four UK nations. It estimates around 28,400 cancer deaths each year in the UK could in theory be avoided if the entire population had the same age-specific cancer mortality rates as the least deprived. Analysis by cancer type shows almost half (47%) of deprivation-associated cancer deaths in the UK are from lung cancer, and a significant deprivation gap exists for deaths from all broad cancer types. The reasons for inequality in cancer mortality are complex and run across the entire cancer pathway. They may include higher prevalence of key risk factors including smoking and obesity, as well as an increased likelihood of being diagnosed later, and with more comorbidities.</p>

<p><a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.cancerresearchuk.org%2Fsites%2Fdefault%2Ffiles%2Fmortality_by_deprivation_analysis_brief.pdf%3F11&amp;data=05%7C02%7CRachel.Franklin%40cancer.org.uk%7C313b1d73196e4ca0f7e508dd581ee63d%7C4473892f71e046fc8dec273902b51349%7C0%7C0%7C638763611931050861%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=VWMoNM1cn5SBTqJGJnkMql%2BuYlnclGcNTdeXsrBMAdo%3D&amp;reserved=0" title="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.cancerresearchuk.org%2Fsites%2Fdefault%2Ffiles%2Fmortality_by_deprivation_analysis_brief.pdf%3F11&amp;data=05%7C02%7CRachel.Franklin%40cancer.org.uk%7C313b1d73196e4ca0f7e508dd581ee63d%7C447">Mortality by Deprivation Analysis</a>full report</p>
</div></div><div class="info_slide info_slide_78223"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_head_shoulders_x3_magenta1.png?itok=SkKAbiLF" alt="Graphic showing head and shoulders of 3 people blocked out in pink"></div><div class="info_title_wrapper"><p class="slide_title info_title">Cancer incidence by broad ethnic group</p><p class="slide_name"></p></div><div class="slide_body"><p>A study analyzed cancer incidence rates in England from 2013 to 2017, focusing on differences among broad ethnic groups. Overall, non-White minority ethnic groups had lower cancer risks compared to the White population. However, notable exceptions included higher rates of prostate cancer in Black males (2.1 times higher), myeloma in Black individuals (2.73.0 times higher), and certain gastrointestinal cancers in Black (1.11.9 times higher) and Asian (1.42.2 times higher) populations. These findings highlight the need to understand the reasons behind these variations and their potential impact on cancer services and patient outcomes.<br>
</p>

<p>Read the<a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F35233092%2F&amp;data=05%7C02%7CRachel.Franklin%40cancer.org.uk%7C313b1d73196e4ca0f7e508dd581ee63d%7C4473892f71e046fc8dec273902b51349%7C0%7C0%7C638763611931064981%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=DB8LXAjK0QSJFE53DC9lE68usZ5JJQs%2FP%2BGxTtc41fI%3D&amp;reserved=0" title="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F35233092%2F&amp;data=05%7C02%7CRachel.Franklin%40cancer.org.uk%7C313b1d73196e4ca0f7e508dd581ee63d%7C4473892f71e046fc8dec273902b51349%7C0%7C0%7C638763611931064981%7CUnk">Cancer incidence by broad ethnic group</a>report</p>
</div></div><div class="info_slide info_slide_78224"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_incidence_people_together_cyan1.png?itok=cBFCvhqG" alt="Icon male and female figure in cyan"></div><div class="info_title_wrapper"><p class="slide_title info_title">25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK</p><p class="slide_name"></p></div><div class="slide_body"><p>A study analyzed cancer incidence and mortality trends in the UK among adults aged 35-69 from 1993 to 2018. Cancer cases increased by 57% in men and 48% in women, with age-standardized rates rising by 0.8% annually for both sexes. Prostate and breast cancers were major contributors to these increases. Conversely, cancer deaths decreased by 20% in men and 17% in women, with age-standardized mortality rates declining by 37% in men and 33% in women. These trends reflect advancements in prevention, early detection, and treatment.<br>
</p>

<p>View<a href="https://pubmed.ncbi.nlm.nih.gov/38479774/"><span><span><span>25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK</span></span></span></a>full report.</p>
</div></div><div class="info_slide info_slide_78225"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_mortality_magenta1.png?itok=lWscj6Vh" alt="Icon showing mortality in magenta"></div><div class="info_title_wrapper"><p class="slide_title info_title">Years of life lost due to cancer in the United Kingdom from 1988 to 2017</p><p class="slide_name"></p></div><div class="slide_body"><p>A study published in the British Journal of Cancer analyzed cancer mortality data from 1988 to 2017 in the UK, focusing on years of life lost (YLL) due to cancer. The research found that approximately 2.2 million years of life are lost to cancer each year in the UK, with lung cancer accounting for about a fifth of this total. Other cancers contributing significantly to YLL include bowel and breast cancers. The study highlights the substantial impact of cancer on premature mortality and underscores the importance of early detection and effective treatment strategies.</p>

<p>Full <a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41416-023-02422-8&amp;data=05%7C02%7CRachel.Franklin%40cancer.org.uk%7C313b1d73196e4ca0f7e508dd581ee63d%7C4473892f71e046fc8dec273902b51349%7C0%7C0%7C638763611931092868%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=FWW5bhd4Yg%2FNk%2BKn5Pzl%2BNHGPU7KsXXjPGmjZrnt%2F8c%3D&amp;reserved=0" title="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41416-023-02422-8&amp;data=05%7C02%7CRachel.Franklin%40cancer.org.uk%7C313b1d73196e4ca0f7e508dd581ee63d%7C4473892f71e046fc8dec273902b51349%7C0%7C0%7C638763611931092">Years of life lost due to cancer in the United Kingdom from 1988 to 2017</a>report.</p>
</div></div><div class="info_slide info_slide_78278"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_survival_navy1.png?itok=eCmWcAKV" alt="Icon showing navy blue figure with arm in the air"></div><div class="info_title_wrapper"><p class="slide_title info_title">10-Year survival by stage for the East of England</p><p class="slide_name"></p></div><div class="slide_body"><p>In partnership with the National Cancer Registration Services (NCRAS), we have produced 10 year survival by stage estimates for the East of England. 10 year survival gives cancer patients a more accurate reflection of their long term survival experience and this work focuses on the differences in survival by stage at diagnosis. The work highlights the need for continued efforts to achieve diagnosis at earlier stages to improve longer term cancer outcomes. The results for lung, breast, bowel and prostate cancer are shown indicating 10 year survival is much poorer when diagnosed at the latest stage compared to the earlier stages. More information about the method used and wider range of site estimates produced can be found in this <a href="https://webarchive.nationalarchives.gov.uk/ukgwa/20231021103513/http://www.ncin.org.uk/about_ncin/10yearsurvival">technical report.</a></p>

<p><a href="/sites/default/files/infographic_10y_survival_by_stage_screen_blog.pdf">See the infographic here</a></p>
</div></div></div><div class="info_gallery_nav" id="info_gallery_nav_3"><ol class="info_links equal_height_links"><li id="info_gallery_link_" class="info_link info_gallery_link_78687"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_graph_arrow_economic_benefits_magenta1.png?itok=sCyZtRzp" alt=""></div><div class="link_bg"><p class="link_title">Economic losses due to cancer mortality in the UK</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_78314"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/small_-_jpg-icon_survival_cyan1.jpg?itok=Q_A9oMAx" alt=""></div><div class="link_bg"><p class="link_title">1- and 5- year conditional survival</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_78221"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_mortality_navy1.png?itok=AGM2vRHd" alt=""></div><div class="link_bg"><p class="link_title">Cancer cases and deaths in the current parliamentary term</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_78222"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_mortality_cyan1.png?itok=-M4fM431" alt=""></div><div class="link_bg"><p class="link_title">Mortality by Deprivation Analysis</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_78223"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_head_shoulders_x3_magenta1.png?itok=SkKAbiLF" alt=""></div><div class="link_bg"><p class="link_title">Cancer incidence by broad ethnic group</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_78224"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_incidence_people_together_cyan1.png?itok=cBFCvhqG" alt=""></div><div class="link_bg"><p class="link_title">25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_78225"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_mortality_magenta1.png?itok=lWscj6Vh" alt=""></div><div class="link_bg"><p class="link_title">Years of life lost due to cancer in the United Kingdom from 1988 to 2017</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_78278"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_survival_navy1.png?itok=eCmWcAKV" alt=""></div><div class="link_bg"><p class="link_title">10-Year survival by stage for the East of England</p><p class="link_name"></p></div></a></li></ol></div></div></div>


</div>
<div class="panel-separator"></div><div class="fieldable-panels-pane">
    

<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"> <p><a id="cancerwaitingtimes" name="cancerwaitingtimes"></a></p>
 </div>
        </div>
</div>
<div class="panel-separator"></div>
<div class="panel-pane pane-fieldable-panels-pane pane-current-154334 pane-bundle-cruk-info-gallery">
  
      <h2 class="pane-title">
  Cancer Waiting Times </h2>



<div class="pane-content">
  <div class="info-gallery info-gallery-id-5" id="info-gallery-id-5"><div class="pane_body"></div><div class="field-items"><div class="info_slide info_slide_78114"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_ai_image_analysis_navy.png?itok=Anb7VNhP" alt="navy icon of magnifying glass over document"></div><div class="info_title_wrapper"><p class="slide_title info_title"> Cancer Waiting Times Parliamentary term projections</p><p class="slide_name"></p></div><div class="slide_body"><p>Understanding future volume on cancer pathways is important from a health systems planning perspective. This project estimates the level of demand the health system could face during the next five years by projecting current Cancer Waiting times metrics in England to the end of the current parliamentary term, focusing on the 31-day and 62-day metrics as well as looking at the number of urgent referrals entering the pathway.</p>

<p>Cancer Research UK, 2025. CRUK analysis brief:</p>

<div class="more"><a href="/sites/default/files/cwt_projections_2024.pdf?11">Download the report</a></div>
</div></div><div class="info_slide info_slide_74611"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/blue-stats-icon_1.png?itok=oOsTIkp9" alt="Blue Stats Icon "></div><div class="info_title_wrapper"><p class="slide_title info_title"> Performance measures across the cancer pathway: Key Stats</p><p class="slide_name"></p></div><div class="slide_body"><p>COVID-19s effect on cancer patients is a key concern to the cancer community with delayed or decreased diagnosis, tests and treatment. To understand this variable and rapidly changing landscape the Cancer Intelligence team are regularly monitoring published data around the impact of the pandemic across the cancer pathway.We have prepared some key insights which reports latest data across the UK (and where possible for the devolved nations) on screening, urgent suspected referrals, diagnostic tests and treatment.</p>

<p>Cancer Intelligence Team, Cancer Research UK. <a href="/sites/default/files/performance_measures_across_the_cancer_pathway.pdf">Performance measures across the cancer pathway: Key Stats</a>Updated July 2025.</p>
</div></div><div class="info_slide info_slide_75473"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/navy-stats-icon.png?itok=yMQhLxv6" alt="Stats icon"></div><div class="info_title_wrapper"><p class="slide_title info_title">Cancer Waiting Times and Diagnostic Activity Data Hub </p><p class="slide_name"></p></div><div class="slide_body"><p>The CRUK Cancer Intelligence Teams Cancer Waiting Times and Diagnostic Activity Data Hub gathers the latest data from across the UK on cancer waiting times performance and diagnostic activity and waiting times. You can view breakdowns for some of this information by a specific cancer site and country.</p>

<div class="more"><a href="https://crukcancerintelligence.shinyapps.io/CancerServicesWaitingTimes/">Explore our Cancer Waiting Times and Diagnostic Activity Data Hub</a></div>
</div></div><div class="info_slide info_slide_76909"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_stopwatch_navy.png?itok=a1peedHl" alt="Navy stopwatch icon"></div><div class="info_title_wrapper"><p class="slide_title info_title">Which cancer patients experience long waits to treatment, and why?</p><p class="slide_name"></p></div><div class="slide_body"><p data-ccp-props="0}" lang="EN-US" paraeid="{b5b3f6fd-c49f-4334-8840-ed1d09ddcff0}{197}" paraid="0">NHS England has a target that at least 85% of patients should start their first treatment for cancer within 62 days of an urgent GP referral for suspected cancer. However, performance against this target has significantly deteriorated in recent years and the number of patients on this pathway waiting over 104 days has been increasing in recent years.</p>

<p data-ccp-props="0}" lang="EN-US" paraeid="{b5b3f6fd-c49f-4334-8840-ed1d09ddcff0}{200}" paraid="0">NHS England release monthly data summarising performance against Cancer Waiting Times (CWT) targets. However, these releases do not provide demographic breakdowns or allow an understanding of why lengthy waits are occurring. This project has used the detailed CWT dataset and the Rapid Cancer Registration Dataset to look at the demographics and other characteristics associated with patients who waited longer than 104 days in 2017/2018, 2020/2021, 2021/2022 and the first two quarters of 2022/2023, and the reported reasons for delay, to inform efforts to reduce the variation in long-waits and decrease their frequency overall, to ensure all patients receive timely treatment.</p>

<p>Wills, L. Cancer Intelligence Team, Cancer Research UK:</p>

<div class="more"><a href="/sites/default/files/long_waiters_report_24.pdf?11">Which cancer patients experience long waits to treatment, and why? July 2024.</a></div>

<p><a href="/sites/default/files/breast_cancer_supplementary_analysis.pdf">Breast cancer supplementary analysis</a> <a href="/sites/default/files/cancer_of_unknown_primary_supplementary_analysis.pdf">Cancer of unknown primary supplementary analysis</a> <a href="/sites/default/files/gynaecological_cancer_supplementary_analysis.pdf">Gynaecological cancer supplementary analysis</a> <a href="/sites/default/files/haematological_cancer_supplementary_analysis.pdf">Haematological cancer supplementary analysis</a> <a href="/sites/default/files/head_and_neck_cancer_supplementary_analysis.pdf">Head and neck cancer supplementary analysis</a> <a href="/sites/default/files/lower_gi_cancer_supplementary_analysis.pdf">Lower GI cancer supplementary analysis</a> <a href="/sites/default/files/lung_cancer_supplementary_analysis.pdf">Lung cancer supplementary analysis</a> <a href="/sites/default/files/sarcoma_supplementary_analysis.pdf">Sarcoma supplementary analysis</a> <a href="/sites/default/files/skin_cancer_supplementary_analysis.pdf">Skin cancer supplementary analysis</a> <a href="/sites/default/files/upper_gi_cancer_supplementary_analysis.pdf">Upper GI cancer supplementary analysis</a> <a href="/sites/default/files/urological_cancer_supplementary_analysis.pdf">Urological cancer supplementary analysis</a></p>
</div></div></div><div class="info_gallery_nav" id="info_gallery_nav_5"><ol class="info_links equal_height_links"><li id="info_gallery_link_" class="info_link info_gallery_link_78114"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_ai_image_analysis_navy.png?itok=Anb7VNhP" alt=""></div><div class="link_bg"><p class="link_title"> Cancer Waiting Times Parliamentary term projections</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_74611"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/blue-stats-icon_1.png?itok=oOsTIkp9" alt=""></div><div class="link_bg"><p class="link_title"> Performance measures across the cancer pathway: Key Stats</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_75473"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/navy-stats-icon.png?itok=yMQhLxv6" alt=""></div><div class="link_bg"><p class="link_title">Cancer Waiting Times and Diagnostic Activity Data Hub </p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_76909"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_stopwatch_navy.png?itok=a1peedHl" alt=""></div><div class="link_bg"><p class="link_title">Which cancer patients experience long waits to treatment, and why?</p><p class="link_name"></p></div></a></li></ol></div></div></div>


</div>
<div class="panel-separator"></div><div class="fieldable-panels-pane">
    

<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"> <p><a id="covid19" name="covid19"></a></p>
 </div>
        </div>
</div>
<div class="panel-separator"></div>
<div class="panel-pane pane-fieldable-panels-pane pane-current-133366 pane-bundle-cruk-info-gallery">
  
      <h2 class="pane-title">
  Covid-19 and Cancer </h2>



<div class="pane-content">
  <div class="info-gallery info-gallery-id-7" id="info-gallery-id-7"><div class="pane_body"></div><div class="field-items"><div class="info_slide info_slide_78306"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/small_-_jpg-icon_coronavirus_magenta_cmyk_1.jpg?itok=6Hoen_l5" alt="Covid19 icon"></div><div class="info_title_wrapper"><p class="slide_title info_title">Impact of COVID-19 on the management and treatment of bowel and lung cancer</p><p class="slide_name"></p></div><div class="slide_body"><p>The COVID-19 pandemic significantly impactedhealthcare servicesin Wales, resulting in rapid reorganisation of resourcesto be deployed to deal with the influx of COVID-19 patients. This analysis aims to understand the effect of this disruption on Welsh cancer patients across the cancer pathway,for bowel and lung cancer.Focussing specifically on symptom reporting, waiting times, diagnostic tests, hospital access and treatment, this analysis hopes to help improvetheunderstandingof which parts of the cancer pathway were most affected and how they could be better protected in any future healthcare crises.</p>

<p><a href="/sites/default/files/covid19_impact_wales_bowel_and_lung.pdf">View the report here</a></p>
</div></div><div class="info_slide info_slide_71516"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/covid-icon.png?itok=cnqvEqik" alt="COVID-19 Icon"></div><div class="info_title_wrapper"><p class="slide_title info_title">Impact of the COVID-19 pandemic on cancer surgery and cancer mortality</p><p class="slide_name"></p></div><div class="slide_body"><p>This research report from Telstra Health UK and Cancer Research UK explores the potential impact of the COVID-19 pandemic on cancer surgery and cancer mortality, both at the very beginning and throughout 18 months of living with the disruption, fear, and strain. The analysis reveals a general decrease in patients undergoing cancer surgery at the start of the pandemic for all demographic groups, but shows that for the most part the recovery period of the COVID-19 pandemic has not exacerbated inequalities in access to cancer surgery. However we know that there are disparities in access to treatment particularly by age, as well as some evidence of variation by deprivation and region. The report also highlights changes in cancer mortality and place of death. Overall it is shown that there was a profound and sustained impact on cancer services and patients but the true extent of these effects is not yet fully understood.</p>

<p><a href="/sites/default/files/telstra-health-uk-cruk-report.pdf">View the report here</a></p>
</div></div><div class="info_slide info_slide_67201"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/small_-_jpg-icon_coronavirus_magenta_cmyk_1.jpg?itok=6Hoen_l5" alt="Covid19 icon"></div><div class="info_title_wrapper"><p class="slide_title info_title">Cancer &amp; COVID-19 Research Summit</p><p class="slide_name"></p></div><div class="slide_body"><p>Cancer Research UK (CRUK), The National Cancer Research Institute (NCRI) and Public Health Englands National Disease Registration Service (PHE NCRAS) hosted a Cancer/COVID-19 Research Summit with researchers from different disciplines to identify key research themes or questions around COVID-19s impact on cancer prevention, early diagnosis and screening. Also, to discuss how the impact of COVID-19 on cancer patients can be mitigated through effective research.</p>

<p>Several areas in which further research is needed were identified, as well as lessons from the pandemic to improve research, cancer care, and help prepare for future crises. These include understanding the biological and psychological effects of COVID-19 on cancer patients, risk factors associated with COVID-19 and cancer, the influence of COVID-19 on health-related behaviours and the impact of COVID-19 on cancer care pathways. <a href="/sites/default/files/cancer_covid-19_research_summit_nov_2020_report_171220.pdf">The full meeting report can be found here.</a></p>
</div></div><div class="info_slide info_slide_67196"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/covid-icon.png?itok=cnqvEqik" alt="COVID-19 Icon"></div><div class="info_title_wrapper"><p class="slide_title info_title">The impact of COVID-19 on cancer patients experience</p><p class="slide_name"></p></div><div class="slide_body"><p>This report summarises the findings from the CRUK patient experience survey (PES), which collected data from 1st May to 28th May 2020. The findings indicate the impact of COVID-19 on cancer patients, and their testing, treatment and care. For many cancer patients the COVID-19 pandemic appears to have had a significant impact on their testing and treatment, and most notably their care. This has resulted in a negative impact on the emotional well-being of many cancer patients whether they were hoping to finish their treatment, find out the results of their test, have their regular screening, or continue with care that could support them, in some cases for the remainder of their life.</p>

<p>Cancer Research UK. <a href="/sites/default/files/pes-covid_2020.pdf">Cancer Research UK Cancer Experience Survey 2020: The impact of COVID-19 on Cancer patients in the UK</a>. July 2020.</p>
</div></div></div><div class="info_gallery_nav" id="info_gallery_nav_7"><ol class="info_links equal_height_links"><li id="info_gallery_link_" class="info_link info_gallery_link_78306"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/small_-_jpg-icon_coronavirus_magenta_cmyk_1.jpg?itok=6Hoen_l5" alt=""></div><div class="link_bg"><p class="link_title">Impact of COVID-19 on the management and treatment of bowel and lung cancer</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_71516"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/covid-icon.png?itok=cnqvEqik" alt=""></div><div class="link_bg"><p class="link_title">Impact of the COVID-19 pandemic on cancer surgery and cancer mortality</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_67201"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/small_-_jpg-icon_coronavirus_magenta_cmyk_1.jpg?itok=6Hoen_l5" alt=""></div><div class="link_bg"><p class="link_title">Cancer &amp; COVID-19 Research Summit</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_67196"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/covid-icon.png?itok=cnqvEqik" alt=""></div><div class="link_bg"><p class="link_title">The impact of COVID-19 on cancer patients experience</p><p class="link_name"></p></div></a></li></ol></div></div></div>


</div>
<div class="panel-separator"></div><div class="fieldable-panels-pane">
    

<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"> <p><a id="treatment" name="treatment"></a></p>
 </div>
        </div>
</div>
<div class="panel-separator"></div>
<div class="panel-pane pane-fieldable-panels-pane pane-current-133401 pane-bundle-cruk-info-gallery">
  
      <h2 class="pane-title">
  Treatment and post diagnosis </h2>



<div class="pane-content">
  <div class="info-gallery info-gallery-id-9" id="info-gallery-id-9"><div class="pane_body"></div><div class="field-items"><div class="info_slide info_slide_67291"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/medical_icon_endometrial.png?itok=bfj5wu8c" alt="medical icon highlighting endometrial cancer"></div><div class="info_title_wrapper"><p class="slide_title info_title">Geographic variation in treatment of endometrial Cancer</p><p class="slide_name"></p></div><div class="slide_body"><p><a id="NICErec" name="NICErec"></a>Our CRUK-PHE partnership team have investigated the geographic variation in the use of lymphonodectomy and external beam radiotherapy (EBRT) in the treatment of endometrial cancer. Significant variation was found between 19 Cancer Alliances using population level cancer registry data collected between 2013-2016, which is likely due to ambiguity in existing endometrial cancer management guidelines.</p>

<p>White B, Nordin A, Fry A et al. <a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fobgyn.onlinelibrary.wiley.com%2Fdoi%2Fabs%2F10.1111%2F1471-0528.15914%3Faf%3DR&amp;data=01%7C01%7CTori.Howard%40cancer.org.uk%7C364e105263f2416998d508d7ca766db3%7C4473892f71e046fc8dec273902b51349%7C1&amp;sdata=GlqaCoFsn7m8nptzWExl89wmXNBZYbSd3Qv0rQHxI4M%3D&amp;reserved=0">Geographic variation in the use of lymphadenectomy and externalbeam radiotherapy for endometrial cancer: a crosssectional analysis of populationbased data.</a> BJOG 2019 doi: 10.1111/1471-0528.15914</p>
</div></div><div class="info_slide info_slide_77418"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/small_png-medical_icon_lung.png?itok=OTBqiGmd" alt="Lung icon"></div><div class="info_title_wrapper"><p class="slide_title info_title">Evaluating concordance with non-small cell lung and colon cancer NICE treatment guideline recommendations</p><p class="slide_name"></p></div><div class="slide_body"><p>Our CRUK  NHS England partnership team have investigated variation in concordance to recommendations from NICE treatment guidelines for colon and non-small cell lung cancer by patient characteristics and Cancer Alliance. Concordance differed between the recommendations, but there were generally associations between age group, comorbidity score, and stage and the likelihood of receiving recommended treatment.</p>

<p>Wills, L. Cancer Intelligence Team, Cancer Research UK:</p>

<p><a href="/sites/default/files/nice_guideline_recommendation_concordance_report_lung_24.pdf">Non-small cell lung cancer treatment guideline recommendation concordance report</a></p>

<p><a href="/sites/default/files/nice_guideline_recommendation_concordance_report_colon_2024.pdf">Colon cancer treatment guideline recommendation concordance report</a></p>
</div></div></div><div class="info_gallery_nav" id="info_gallery_nav_9"><ol class="info_links equal_height_links"><li id="info_gallery_link_" class="info_link info_gallery_link_67291"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/medical_icon_endometrial.png?itok=bfj5wu8c" alt=""></div><div class="link_bg"><p class="link_title">Geographic variation in treatment of endometrial Cancer</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_77418"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/small_png-medical_icon_lung.png?itok=OTBqiGmd" alt=""></div><div class="link_bg"><p class="link_title">Evaluating concordance with non-small cell lung and colon cancer NICE treatment guideline recommendations</p><p class="link_name"></p></div></a></li></ol></div></div></div>


</div>
<div class="panel-separator"></div><div class="fieldable-panels-pane">
    

<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"> <p><a id="risk" name="risk"></a></p>
 </div>
        </div>
</div>
<div class="panel-separator"></div>
<div class="panel-pane pane-fieldable-panels-pane pane-current-133376 pane-bundle-cruk-info-gallery">
  
      <h2 class="pane-title">
  Risk factors and symptom awareness</h2>



<div class="pane-content">
  <div class="info-gallery info-gallery-id-11" id="info-gallery-id-11"><div class="pane_body"></div><div class="field-items"><div class="info_slide info_slide_78097"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_smoking_navy.png?itok=kDS6RQPZ" alt="navy cigarette icon"></div><div class="info_title_wrapper"><p class="slide_title info_title">Smoking prevalence projections for England, Wales, Scotland and Northern Ireland using data to 2023 </p><p class="slide_name"></p></div><div class="slide_body"><p paraeid="{027df94c-32ef-437b-ba99-b03e0ab1c77f}{49}" paraid="54564775">Smoking is the leading cause of cancer and preventable death in the UK. Smoking prevalence has been declining across the UK for some decades yet there are still around 4.9 million people who smoke in England, more than 325,000 who smoke in Wales, more than 689,000 in Scotland and more than 206,000 who smoke in Northern Ireland. Smoking prevalence remains higher in more deprived groups.</p>

<p paraeid="{027df94c-32ef-437b-ba99-b03e0ab1c77f}{65}" paraid="1416615853">England, Scotland and Wales have government-set smokefree ambitions to achieve 5% average adult smoking prevalence by 2030 in England and Wales, and 2034 in Scotland. There is currently no ambition to achieve smokefree in Northern Ireland.</p>

<p paraeid="{027df94c-32ef-437b-ba99-b03e0ab1c77f}{75}" paraid="531706150">In this report we estimate whether the smokefree ambitions are likely to be realised based on recent trends, and when smokefree will be achieved for each deprivation decile. We have projected average adult smoking prevalence, and smoking prevalence by deprivation decile for England and Wales, and by deprivation quintile for Scotland and Northern Ireland, until 2050. These projections use smoking prevalence data up to 2023, where possible, from the Office for National Statistics (ONS) Annual Population Survey, Scottish Health Survey and Health Survey Northern Ireland.</p>

<p paraeid="{027df94c-32ef-437b-ba99-b03e0ab1c77f}{103}" paraid="1735239240">The results indicate that although smoking prevalence rates are decreasing, if current adult smoking prevalence trends continue, none of the UK constituent nations will achieve their smokefree ambitions. The most deprived quintiles and deciles in each of the nations are expected to be the furthest away from achieving smokefree targets and could be more than two decades behind the least deprived; none of the most deprived groups are projected to reach smokefree by 2050. </p>

<div class="more"><a href="/sites/default/files/final_smoking_projections_uk_2023.pdf?11">View the full Smoking prevalence projections for England, Wales, Scotland and Northern Ireland report</a></div>
</div></div><div class="info_slide info_slide_77633"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_ai_image_analysis_navy.png?itok=Anb7VNhP" alt="navy icon of magnifying glass over document"></div><div class="info_title_wrapper"><p class="slide_title info_title">Projected UK cancer cases caused by tobacco in the current parliamentary term</p><p class="slide_name"></p></div><div class="slide_body"><p>Smoking is the biggest cause of cancer and death in the UK. Estimates of the population-level burden of smoking-attributable cancer are useful to galvanise policymakers to try to reduce smoking rates. This analysis brief presents estimates of the total number of cancer cases expected to be caused by smoking over the current parliamentary term in the UK, and for the same time period in each of the devolved nations.</p>

<p>The projected number of smoking-attributable cancer cases in the UK from July 2024  July 2029 was estimated using the well-established population attributable fractions (PAFs) method. The analysis dataset was compiled from projected cancer incidence based on gold-standard cancer registration data, representative population surveys of self-reported smoking and smoke exposure, and meta- or pooled analyses examining the relative risk of cancer in people who currently smoke, used to smoke, or have been exposed to other peoples smoke, versus people who have never smoked or been exposed. Analysis was split by cancer site, sex, age-band, and UK nation, and combined to obtain UK-wide figures.</p>

<p>The results find that almost 300,000 cancer cases are projected to be caused by smoking in the current parliamentary term in the UK. Around 2,800 of these cases are expected to be caused by secondhand smoke exposure in people who have never smoked.</p>

<div class="more"><a href="/sites/default/files/projected_uk_cancer_cases_caused_by_tobacco.pdf?11">View the report</a></div>
</div></div><div class="info_slide info_slide_77632"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_smoking_navy.png?itok=kDS6RQPZ" alt="navy cigarette icon"></div><div class="info_title_wrapper"><p class="slide_title info_title">Smoking - attributable cancer cases in the UK</p><p class="slide_name"></p></div><div class="slide_body"><p>Smoking is the biggest cause of cancer and death in the UK. It causes at least 16 types of cancer. Smoking prevalence in the UK has been falling for decades; however, the pace of change has varied by sex and age (among other characteristics), and people who used to smoke also have elevated cancer risk compared with people who have never smoked.</p>

<p>The number and proportion of smoking-attributable cancer cases in the UK in 2003, 2013, and 2023 were calculated using the well-established population attributable fractions (PAFs) method. The analysis dataset was compiled from gold-standard cancer registration data, representative population surveys of self-reported smoking and smoke exposure, and meta- or pooled analyses examining the relative risk of cancer in people who currently smoke, used to smoke, or have been exposed to other peoples smoke, versus people who have never smoked or been exposed. Analysis was split by cancer site, sex, age-band, and UK nation, and combined to obtain UK-wide figures.</p>

<p>The results find that the estimated proportion of UK cancer cases attributable to smoking has decreased over the past two decades, from 17% in 2003 to 14% in 2023. The estimated number of smoking-attributable cases has increased over this period, from around 48,900 in 2003 to around 57,800 in 2023. The estimated proportion of cancer cases attributable to smoking in 2023 was higher in males (16%) than females (13%), and highest within the UK nations in Scotland. Almost 6 in 10 (57%) UK smoking-attributable cancer cases in 2023 were lung cancer (around 33,100).</p>

<div class="more"><a href="/sites/default/files/analysis_brief_smoking_attributable_cancer_cases_in_the_uk_2003-2023.pdf?11">View the report</a></div>
</div></div><div class="info_slide info_slide_70911"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_coin_navy.png?itok=UeIJqhU0" alt="Coin icon "></div><div class="info_title_wrapper"><p class="slide_title info_title">Socio-economic deprivation and cancer incidence in England: Quantifying the role of smoking</p><p class="slide_name"></p></div><div class="slide_body"><p>Smoking is the leading cause of preventable cancer and death in the UK. Deprived populations typically experience higher rates of smoking and cancer incidence. We calculated the proportion and number of smoking-related cancer cases by deprivation quintile in England and modelled how smoking contributes to the deprivation gap for cancer incidence. We found a strong deprivation gradient for the proportion of cancer cases attributable to smoking in England. Our modelling suggests that more than half (61%) of the deprivation gap for cancer incidence could have been prevented if nobody smoked, indicating smoking to be the key driver for cancer incidence inequality in England.</p>

<div class="more"><a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0272202#references">View the peer reviewed journal article </a></div>

<p>Payne NWS, Brown KF, Delon C et al. Socio-economic deprivation and cancer incidence in England: Quantifying the role of smoking. PLOS ONE 2022 17(9): e0272202</p>
</div></div><div class="info_slide info_slide_67296"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_scales_overweight_navy.png?itok=I0hGQw6T" alt="navy icon of scales "></div><div class="info_title_wrapper"><p class="slide_title info_title">Adult overweight and obesity prevalence projections for the UK</p><p class="slide_name"></p></div><div class="slide_body"><p>Overweight and obesity is a major risk factor for the leading causes of death in the world and is causally associated with at least 13 different types of cancer. Overweight and obesity prevalence has increased markedly in the UK in recent decades. We provide projections for overweight and obesity prevalence by sex and deprivation quintile in the UK (where possible) and its constituent nations. These projections, based on current trends in nationally representative health surveys, suggest that there could be more people who are obese than healthy weight in the UK by 2040. In England and Scotland, the deprivation gap for obesity between the least and most deprived is projected to increase by more than half.</p>

<div class="more"><a href="/sites/default/files/cancer-stats/adult_overweight_and_obesity_prevalence_projections_18-05/adult_overweight_and_obesity_prevalence_projections_18-05.pdf">View the report</a></div>
</div></div><div class="info_slide info_slide_67236"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/small_-_jpg-icon_question_mark_01_magenta.jpg?itok=OOk7lTWx" alt="Pink question mark icon"></div><div class="info_title_wrapper"><p class="slide_title info_title">Patients with non-specific symptoms</p><p class="slide_name"></p></div><div class="slide_body"><p>The CRUK-PHE partnership have published a paper comparing patients presenting with non-specific but concerning symptoms with patients presenting with more obvious symptoms. Cancer registration data was linked to the National Cancer and Diagnosis Audit (NCDA) data, which has information about primary care for over 17,000 cancers. The work found that patients with non-specific symptoms had longer primary care intervals, more complex diagnostic pathways and were more likely to be diagnosed at stage 4 and after an emergency presentation. This work supports the evaluation of Multi-Disciplinary Centres (MDCs) by the ACE Programme, an early diagnosis imitative supported by CRUK, MacMillan Cancer Support and NHS England.</p>

<p>PearsonC,PoirierV,FitzgeraldK, et al. <a href="https://bmjopen.bmj.com/content/10/1/e033008">Cross-sectional study using primary care and cancer registration data to investigate patients with cancer presenting with non-specific symptoms.</a> BMJ Open2020;<strong>10:</strong>e033008.doi:10.1136/bmjopen-2019-033008</p>
</div></div><div class="info_slide info_slide_67241"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_scales_overweight_navy.png?itok=I0hGQw6T" alt="navy icon of scales "></div><div class="info_title_wrapper"><p class="slide_title info_title">Cancers attributable to overweight and obesity by deprivation</p><p class="slide_name"></p></div><div class="slide_body"><p>This report investigates to what extent the proportion of overweight and obesity attributable cancer cases in the UK varies with deprivation. For females, the proportion of cancer cases attributable to overweight and obesity showed a 10-29% relative increase from the least deprived quintile to the most deprived. The deprivation gap was generally much smaller for males. There is a stronger deprivation gradient for obesity prevalence in UK females compared to males, and more overweight and obesity-associated cancer types in females compared to males, which explains the differences observed between sexes.</p>

<p>Cancer Intelligence Team, Cancer Research UK. <a href="/sites/default/files/cancer_attributable_overweight_and_obesity_dep_uk.pdf">The fraction of cancer attributable to overweight and obesity by deprivation quintile in the UK</a>. October 2020.</p>
</div></div><div class="info_slide info_slide_67251"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/small_png-icon_smoking_magenta.png?itok=-JeOUQu7" alt="cigarette icon"></div><div class="info_title_wrapper"><p class="slide_title info_title">Smoking trends by occupation group </p><p class="slide_name"></p></div><div class="slide_body"><p>The proportion of current smokers in the population (smoking prevalence) has been falling for decades in the UK, However a clear deprivation gradient remains: smoking prevalence is around twice as high in routine and manual (R&amp;M) workers compared with managerial and professional (M&amp;P) workers. That gap has widened in recent decades, because smoking prevalence has fallen more slowly among R&amp;M workers compared with M&amp;P workers. This reflects both higher rates of uptake and lower rates of quitting in R&amp;M workers compared with M&amp;P workers. Occupation group is associated with smoking behaviour independent of other characteristics like age, sex, region, education, marital status, ethnicity, alcohol consumption and general perceived health. If the R&amp;M worker population had experienced the same pace of decline in smoking prevalence as the M&amp;P population, there would now be almost a million fewer R&amp;M worker smokers.</p>

<p>Cancer Intelligence Team 2019<a href="/sites/default/files/smoking_prevalence_trends_occupation_final_2020.pdf">Smoking prevalence trends by occupation group in health survey for England</a></p>
</div></div></div><div class="info_gallery_nav" id="info_gallery_nav_11"><ol class="info_links equal_height_links"><li id="info_gallery_link_" class="info_link info_gallery_link_78097"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_smoking_navy.png?itok=kDS6RQPZ" alt=""></div><div class="link_bg"><p class="link_title">Smoking prevalence projections for England, Wales, Scotland and Northern Ireland using data to 2023 </p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_77633"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_ai_image_analysis_navy.png?itok=Anb7VNhP" alt=""></div><div class="link_bg"><p class="link_title">Projected UK cancer cases caused by tobacco in the current parliamentary term</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_77632"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_smoking_navy.png?itok=kDS6RQPZ" alt=""></div><div class="link_bg"><p class="link_title">Smoking - attributable cancer cases in the UK</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_70911"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_coin_navy.png?itok=UeIJqhU0" alt=""></div><div class="link_bg"><p class="link_title">Socio-economic deprivation and cancer incidence in England: Quantifying the role of smoking</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_67296"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_scales_overweight_navy.png?itok=I0hGQw6T" alt=""></div><div class="link_bg"><p class="link_title">Adult overweight and obesity prevalence projections for the UK</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_67236"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/small_-_jpg-icon_question_mark_01_magenta.jpg?itok=OOk7lTWx" alt=""></div><div class="link_bg"><p class="link_title">Patients with non-specific symptoms</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_67241"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_scales_overweight_navy.png?itok=I0hGQw6T" alt=""></div><div class="link_bg"><p class="link_title">Cancers attributable to overweight and obesity by deprivation</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_67251"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/small_png-icon_smoking_magenta.png?itok=-JeOUQu7" alt=""></div><div class="link_bg"><p class="link_title">Smoking trends by occupation group </p><p class="link_name"></p></div></a></li></ol></div></div></div>


</div>
<div class="panel-separator"></div><div class="fieldable-panels-pane">
    

<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"> <p><a id="diagnosis" name="diagnosis"></a></p>
 </div>
        </div>
</div>
<div class="panel-separator"></div>
<div class="panel-pane pane-fieldable-panels-pane pane-current-133396 pane-bundle-cruk-info-gallery">
  
      <h2 class="pane-title">
  Diagnosis and Screening </h2>



<div class="pane-content">
  <div class="info-gallery info-gallery-id-13" id="info-gallery-id-13"><div class="pane_body"></div><div class="field-items"><div class="info_slide info_slide_78305"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/medical_icon_bowel.png?itok=q9VLHVDX" alt="Navy icon of a body highlighting the bowel area in pink"></div><div class="info_title_wrapper"><p class="slide_title info_title">GP Bowel Screening Tool</p><p class="slide_name"></p></div><div class="slide_body"><p>We know that socio-demographic factors can affect screening coverage. This tool models how socio-demographic factors may impact screening coverage to produce an estimated local level which is then compared to the actual screening coverage of each GP practice area. This could help identify populations where screening coverage is higher, lower or similar to the level that their socio-demographics would predict, and therefore help systems identify the right strategies to increase screening coverage in those areas. This tool can also provide an idea of where systems may want to target resources when used in conjunction with local knowledge.</p>

<div class="more"><a href="https://crukcancerintelligence.shinyapps.io/GPBowelScreeningTool">Visit our GP Bowel Screening Tool</a>  <a href="/sites/default/files/gp_bowel_tool_user_guide.pdf?11">Download the GP Bowel Screening Tool guide</a></div>
</div></div><div class="info_slide info_slide_78274"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_magnifying_glass_with_cells_magenta1.png?itok=G5xsGfhW" alt="Icon of pink magnifying glass"></div><div class="info_title_wrapper"><p class="slide_title info_title">Emergency diagnosis of cancer: Evidence from the National Cancer Diagnosis Audit </p><p class="slide_name"></p></div><div class="slide_body"><p>Diagnosis of cancer soon after emergency care use is associated with adverse prognosis. This analysis used data from the National Cancer Diagnosis Audit to more precisely explore different definitions of emergency diagnosisand the predictors and consequences of different emergency diagnosis types.Produced in partnership with the National Disease Registration Service and the National Cancer Diagnosis Audit Methodology Group.</p>

<div class="more"><a href="https://www.sciencedirect.com/science/article/pii/S1877782124000869?via%3Dihub">Read the full Emergency diagnosis of cancer: Evidence from the National Cancer Diagnosis Audit report</a></div>
</div></div><div class="info_slide info_slide_78275"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/examining_bar_graph_icon_0.png?itok=Xk2Nlgni" alt="navy icon of magnifying glass over a bar chart"></div><div class="info_title_wrapper"><p class="slide_title info_title">National Cancer Diagnosis Audits for England 2018 versus 2014: a comparative analysis. </p><p class="slide_name"></p></div><div class="slide_body"><p>This analysisused data from the National Cancer Diagnosis Audit to examine possible changesto aspects of the diagnostic process, and its timeliness, before and after publication of the National Institute for Health and Care Excellence's (2015) guidance on the referral of suspected cancer in primary care.Produced in partnership with the National Disease Registration Service and the National Cancer Diagnosis Audit Methodology Group.</p>

<div class="more"><a href="https://bjgp.org/content/73/733/e566">National Cancer Diagnosis Audits for England 2018 versus 2014: a comparative analysisfull report.</a></div>
</div></div><div class="info_slide info_slide_78276"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_clock_navy1_0.png?itok=0SeYYd-r" alt="Icon of a navy blue clock"></div><div class="info_title_wrapper"><p class="slide_title info_title">The frequency, nature and impact of GP-assessed avoidable delays </p><p class="slide_name"></p></div><div class="slide_body"><p>There is a growing emphasis on the speed of diagnosis as an aspect of cancer prognosis. Epidemiological data in the last decade have quantified diagnostic timeliness and its variation. Whether prolonged diagnostic intervals can be considered avoidable has not been assessed in relation to outcomes.This analysis used data from the National Cancer Diagnosis Audit to investigate the frequency, natureand impact of avoidable delays.Produced in partnership with the National Disease Registration Service and the National Cancer Diagnosis Audit Methodology Group.</p>

<div class="more"><a href="https://linkinghub.elsevier.com/retrieve/pii/S1877782119301286">Read the full report - The frequency, nature and impact of GP-assessed avoidable delays</a></div>
</div></div><div class="info_slide info_slide_78277"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_time_delay_magenta1.png?itok=FSeDqnEM" alt="Icon showing a pink clock with an exclamation mark showing a time delay"></div><div class="info_title_wrapper"><p class="slide_title info_title">Diagnosing cancer in primary care: results from the National Cancer Diagnosis Audit </p><p class="slide_name"></p></div><div class="slide_body"><p>Continual improvements in diagnostic processes are needed to minimise the proportion of patients with cancer who experience diagnostic delays. Clinical audit is a means of achieving this. This analysisused data from the National Cancer Diagnosis Audit to characterise key aspects of the diagnostic process for cancer and to generate baseline measures for future re-audit.Produced in partnership with the National Disease Registration Service and The National Cancer Diagnosis Audit Methodology Group.</p>

<div class="more"><a href="https://bjgp.org/content/68/666/e63">View the Diagnosing cancer in primary care: results from the National Cancer Diagnosis Audit report</a></div>
</div></div><div class="info_slide info_slide_73201"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/health_professional_primary_care.png?itok=9r0_24Ig" alt="navy icon of person with magnifying glass over them"></div><div class="info_title_wrapper"><p class="slide_title info_title">Relationship between ethnicity and stage at diagnosis</p><p class="slide_name"></p></div><div class="slide_body"><p>Our CRUK-NHS E partnership team have evaluated whether certain ethnic groups in England are more likely to be diagnosed at a later stage. Reviewing diagnoses of 6 cancer types from 2012-2016 in people belonging to one of 5 ethnic groups, we found that Caribbean, African and Asian women and Caribbean men had increased odds of late-stage disease for certain cancer types compared to the White British cohort. Reasons behind increased late diagnoses may include poorer symptom awareness, delays in seeking help and having to present to the GP multiple times before being referred for tests.</p>

<p>Fry A, White B, Nagarwalla D, et al. <a href="https://bmjopen.bmj.com/content/13/1/e062079">Relationship between ethnicity and stage at diagnosis in England: a national analysis of six cancer sites</a>. BMJ Open 2023. doi: 10.1136/bmjopen-2022-062079</p>
</div></div><div class="info_slide info_slide_67476"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_speed_clock_navy.png?itok=0hcilyTq" alt="Navy icon of clock and arrow depicting speed"></div><div class="info_title_wrapper"><p class="slide_title info_title">Diagnostic Intervals in England</p><p class="slide_name"></p></div><div class="slide_body"><p>Our CRUK-PHE partnership team have calculated diagnostic intervals for the first time for patients of 25 different cancer sites diagnosed in 2014 &amp; 2015. Significant variation in these intervals were found by stage of disease, route to diagnosis and comorbidity score. An online tool demonstrates variation by these and other factors by cancer site and cancer alliance. A paper describing the methodology and results for colorectal and lung cancer was published in Cancer Epidemiology in June 2019. Two blogs detailed the project, one by CRUK and one at Public Health Matters.</p>

<p>Pearson C, Fraser J, Peake M. <a href="/sites/default/files/pearson_et_al._diag_pathway_cancer_epi_2019.pdf">Establishing population-based surveillance of diagnostic timeliness using linked cancer registry and administrative data for patients with colorectal and lung cancer</a>. Cancer Epidemiology 2019.</p>

<div class="more"><a href="https://digital.nhs.uk/ndrs/data/data-outputs/cancer-data-hub/cancer-diagnostic-intervals">Visit the online tool</a>  <a href="https://publichealthmatters.blog.gov.uk/2019/07/01/seven-things-we-learnt-by-measuring-the-length-of-cancer-diagnostic-pathways/">See the Public Health Matters blog</a></div>
</div></div></div><div class="info_gallery_nav" id="info_gallery_nav_13"><ol class="info_links equal_height_links"><li id="info_gallery_link_" class="info_link info_gallery_link_78305"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/medical_icon_bowel.png?itok=q9VLHVDX" alt=""></div><div class="link_bg"><p class="link_title">GP Bowel Screening Tool</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_78274"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_magnifying_glass_with_cells_magenta1.png?itok=G5xsGfhW" alt=""></div><div class="link_bg"><p class="link_title">Emergency diagnosis of cancer: Evidence from the National Cancer Diagnosis Audit </p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_78275"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/examining_bar_graph_icon_0.png?itok=Xk2Nlgni" alt=""></div><div class="link_bg"><p class="link_title">National Cancer Diagnosis Audits for England 2018 versus 2014: a comparative analysis. </p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_78276"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_clock_navy1_0.png?itok=0SeYYd-r" alt=""></div><div class="link_bg"><p class="link_title">The frequency, nature and impact of GP-assessed avoidable delays </p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_78277"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_time_delay_magenta1.png?itok=FSeDqnEM" alt=""></div><div class="link_bg"><p class="link_title">Diagnosing cancer in primary care: results from the National Cancer Diagnosis Audit </p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_73201"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/health_professional_primary_care.png?itok=9r0_24Ig" alt=""></div><div class="link_bg"><p class="link_title">Relationship between ethnicity and stage at diagnosis</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_67476"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_speed_clock_navy.png?itok=0hcilyTq" alt=""></div><div class="link_bg"><p class="link_title">Diagnostic Intervals in England</p><p class="link_name"></p></div></a></li></ol></div></div></div>


</div>
<div class="panel-separator"></div><div class="fieldable-panels-pane">
    

<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"> <p><a id="cancerUK" name="cancerUK"></a></p>
 </div>
        </div>
</div>
<div class="panel-separator"></div>
<div class="panel-pane pane-fieldable-panels-pane pane-current-133506 pane-bundle-cruk-info-gallery">
  
      <h2 class="pane-title">
  Cancer in the UK</h2>



<div class="pane-content">
  <div class="info-gallery info-gallery-id-15" id="info-gallery-id-15"><div class="pane_body"></div><div class="field-items"><div class="info_slide info_slide_78632"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_uk_countries_map_with_borders_navy.png?itok=1TM_97eR" alt="Icon of UK"></div><div class="info_title_wrapper"><p class="slide_title info_title">Cancer in the UK: Overview 2025</p><p class="slide_name"></p></div><div class="slide_body"><p><a id="CITUK" name="CITUK"></a>This report sets out the key challenges facing cancer services and people affected by cancer in the UK today. While we've made huge progress on cancer in the last 50 years, this report show that improvements can be made across the cancer pathway  preventing cancers, diagnosing patients earlier and ensuring patients have access to the best treatment options. The report concludes by setting out the priority actions we believe are vital to addressing challenges and lays out how data-led insights can strengthen our ability to beat cancer for everyone.</p>

<p></p>

<p><span class="button"><a href="/sites/default/files/cancer_in_the_uk_overview_2025.pdf">Cancer in the UK Overview 2025</a></span></p>

<h3></h3>

<h3>Devolved nation summaries are also available</h3>

<div class="more"><a href="/sites/default/files/cancer_in_the_uk_scotland_overview_2025.pdf?11">Cancer in the UK Scotland Overview 2025</a></div>

<div class="more"><a href="/sites/default/files/cancer_in_the_uk_wales_overview_2025.pdf?11">Cancer in the UK Wales Overview 2025</a></div>

<div class="more"><a href="/sites/default/files/cancer_in_the_uk_northern_ireland_overview_2025.pdf?11">Cancer in the UK Northern Ireland Overview 2025</a></div>
</div></div><div class="info_slide info_slide_78203"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/cituk2025.png?itok=l0BsuJ4d" alt="Report cover for Cancer in the UK Socioeconomic deprivation 2025"></div><div class="info_title_wrapper"><p class="slide_title info_title">Cancer in the UK 2025: socio-economic deprivation</p><p class="slide_name"></p></div><div class="slide_body"><p>This report updates Cancer in the UK 2020: Socioeconomic deprivation report and highlights the inequalities linked to socioeconomic deprivation that continue to persist across the cancer pathway.</p>

<p>The report emphasises how significant disparities remain between the most and least deprived groups. Generally, more deprived groups have a higher prevalence of risk factors that can lead to higher rates of cancer incidence. People living in more deprived areas are less aware of symptoms of cancer and report more barriers to seeking help. Participation in screening programmes is lower in more deprived groups and they have higher proportions of cancers diagnosed at a later stage, leading to worse outcomes in survival and mortality. Despite ongoing efforts, these challenging inequalities continue but there are opportunities and positive developments that we can build on to progress in reducing inequalities across the cancer pathway.</p>

<p>Cancer Intelligence Team, Cancer Research UK. <a href="/sites/default/files/cancer_in_the_uk_2025_socioeconomic_deprivation.pdf">Cancer in the UK 2025: Socio-economic deprivation</a>. February 2025.</p>
</div></div><div class="info_slide info_slide_76101"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/untitled_design_14_0.png?itok=1r1sHVul" alt="The UK in cartoon form "></div><div class="info_title_wrapper"><p class="slide_title info_title">Cancer in the UK: Overview 2024</p><p class="slide_name"></p></div><div class="slide_body"><p>This report sets out the key challenges facing cancer services and people affected by cancer. Weve made huge progress on cancer in the last 50 years, but new analysis indicates that improvements in survival have slowed. This next instalment in the Cancer in the UK series highlights the need for political leadership to deliver long-term solutions to the challenges facing cancer research and care.</p>

<p><a href="/sites/default/files/cancer_in_the_uk_overview_2024.pdf">Cancer in the UK: Overview 2024</a></p>

<p>Devolved nation summaries are also available:</p>

<p><a href="/sites/default/files/cancer_in_the_uk_2024_scotland_overview.pdf">Cancer in the UK: Scotland Overview 2024</a></p>

<p><a href="/sites/default/files/cancer_in_the_uk_2024_wales_overview.pdf">Cancer in the UK: Wales Overview 2024</a></p>

<p><a href="/sites/default/files/cancer_in_the_uk_2024_northern_ireland_overview.pdf">Cancer in the UK: Northern Ireland Overview 2024</a></p>
</div></div><div class="info_slide info_slide_67356"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/cancer-inthe-uk-thumbnail.png?itok=vIsF-XOI" alt="Cancer in the UK thumbnail"></div><div class="info_title_wrapper"><p class="slide_title info_title">Cancer in the UK: Overview 2023</p><p class="slide_name"></p></div><div class="slide_body"><p>This report sets out the top line view of key challenges facing cancer services, and people affected by cancer today, looking at where progress is being made and the many challenges we face. With cancer cases projected to rise, ensuring we have a long term, comprehensive plan for cancer that tackles these challenges and harnesses the opportunities is vital.</p>

<p>This report is a call to action  all of us must come together to make progress in our ambition to beat cancer. People affected by cancer deserve no less.</p>

<p><a href="/sites/default/files/cancer_in_the_uk_report-overview-03.pdf">Cancer in the UK: Overview 2023</a></p>

<p>Devolved nation summaries are also available:</p>

<p><a href="/sites/default/files/cancer_in_the_uk_scotland_overview_2023.pdf">Cancer in the UK: Scotland Overview 2023</a></p>

<p><a href="/sites/default/files/cancer_in_the_uk_wales_overview_2023.pdf">Cancer in the UK: Wales Overview 2023</a></p>

<p><a href="/sites/default/files/cancer_in_the_uk_northern_ireland_overview_2023.pdf">Cancer in the UK: Northern Ireland Overview 2023</a></p>
</div></div><div class="info_slide info_slide_71456"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/deprivation-scotlan-thumbnail.png?itok=wPMPSs5w" alt="Publication thumbnail"></div><div class="info_title_wrapper"><p class="slide_title info_title">Cancer in the UK: Deprivation and cancer inequalities in Scotland</p><p class="slide_name"></p></div><div class="slide_body"><p>This report focuses on the impact of deprivation across the cancer pathway in Scotland. Generally, populations with higher deprivation have greater risk factors for cancer, are less aware of symptoms of cancer and report more barriers to seeking help. Their participation in screening programmes is lower and they are more likely to be diagnosed with late-stage disease. People from more deprived populations have worse cancer outcomes, including survival. We need to make sure we push to achieve lower levels of cancer risk factors, better engagement with the health system and improved cancer outcomes for everyone and close the deprivation gap, because beating cancer must mean beating it for everyone.</p>

<p>Cancer Intelligence Team, Cancer Research UK. <a href="/sites/default/files/cancer_in_the_uk_-_deprivation_and_cancer_inequalities_in_scotland.pdf">Cancer in the UK: Deprivation and cancer inequalities in Scotland</a>. November 2022.</p>
</div></div><div class="info_slide info_slide_67351"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/inequalities_report_1.png?itok=wiG85Re7" alt="Cancer in the UK Icon"></div><div class="info_title_wrapper"><p class="slide_title info_title">Cancer in the UK: socio-economic deprivation</p><p class="slide_name"></p></div><div class="slide_body"><p>This report brings together the available evidence across the UK of inequalities in cancer by socio-economic variation and shows the negative experiences and outcomes that people from more deprived groups experience. Generally, populations with higher deprivation have higher prevalence of cancer risk factors, are less aware of symptoms of cancer and report more barriers to seeking help. Their participation in screening programmes is lower and they have higher proportions of cancer diagnosed through routes with worse survival. People from more deprived populations report worse experiences of care and experience inequalities in treatment options. They have worse outcomes. This report presents the evidence for each part of the cancer pathway with examples from all four UK nations.</p>

<p>Cancer Intelligence Team, Cancer Research UK. <a href="/sites/default/files/cancer_inequalities_in_the_uk.pdf">Cancer in the UK 2020: Socio-economic deprivation</a>. September 2020.</p>
</div></div></div><div class="info_gallery_nav" id="info_gallery_nav_15"><ol class="info_links equal_height_links"><li id="info_gallery_link_" class="info_link info_gallery_link_78632"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_uk_countries_map_with_borders_navy.png?itok=1TM_97eR" alt=""></div><div class="link_bg"><p class="link_title">Cancer in the UK: Overview 2025</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_78203"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/cituk2025.png?itok=l0BsuJ4d" alt=""></div><div class="link_bg"><p class="link_title">Cancer in the UK 2025: socio-economic deprivation</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_76101"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/untitled_design_14_0.png?itok=1r1sHVul" alt=""></div><div class="link_bg"><p class="link_title">Cancer in the UK: Overview 2024</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_67356"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/cancer-inthe-uk-thumbnail.png?itok=vIsF-XOI" alt=""></div><div class="link_bg"><p class="link_title">Cancer in the UK: Overview 2023</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_71456"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/deprivation-scotlan-thumbnail.png?itok=wPMPSs5w" alt=""></div><div class="link_bg"><p class="link_title">Cancer in the UK: Deprivation and cancer inequalities in Scotland</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_67351"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/inequalities_report_1.png?itok=wiG85Re7" alt=""></div><div class="link_bg"><p class="link_title">Cancer in the UK: socio-economic deprivation</p><p class="link_name"></p></div></a></li></ol></div></div></div>


</div>
<div class="panel-separator"></div><div class="fieldable-panels-pane">
    

<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"> <p><a id="behaviour" name="behaviour"></a></p>
 </div>
        </div>
</div>
<div class="panel-separator"></div>
<div class="panel-pane pane-fieldable-panels-pane pane-current-136016 pane-bundle-cruk-info-gallery">
  
      <h2 class="pane-title">
  Behavioural Science</h2>



<div class="pane-content">
  <div class="info-gallery info-gallery-id-17" id="info-gallery-id-17"><div class="pane_body"></div><div class="field-items"><div class="info_slide info_slide_74566"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/cruk_obesity_poster.jpg?itok=TGxhTdUu" alt="CRUK obesity poster"></div><div class="info_title_wrapper"><p class="slide_title info_title">Obesity Campaign Evaluation</p><p class="slide_name"></p></div><div class="slide_body"><p>Overweight and obesity is the second biggest preventable cause of cancer after smoking. In 2018, Cancer Research UK launched an awareness raising campaign about the link between overweight and obesity and cancer risk. This study aimed to evaluate the reach and impact of the campaign.The campaign consisted of six elements including the main message that Obesity is a cause of cancer. UK adults and Members of Parliament (MPs) were surveyed before the campaign (W1;n=2124 andn=151), 1 month (W2;n=2050 andn=151) and 3 months after the campaign (W3;n=2059 and MPs not surveyed). Outcome measures were campaign reach, awareness of overweight and obesity as risk factors for cancer, attitudes towards individuals who are overweight or obese, support for policies to reduce obesity and reactions to the campaign. This evaluation suggests that the campaign achieved the primary objective of increasing awareness of the link between obesity and cancer without increasing negative attitudes towards individuals who are overweight or obese.</p>

<div class="more"><a href="https://authors.elsevier.com/sd/article/S0033350623001142">Read the full Obesity Campaign Evaluation</a></div>

<div class="more"><a href="/sites/default/files/obesity_campaign_evaluation.pdf">Download theObesity Campaign Evaluation</a></div>
</div></div><div class="info_slide info_slide_68516"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/mass-media-review-thumbnail.png?itok=-r_afk09" alt="The effect and cost-effectiveness of mass media campaigns on health behaviour change: A narrative systematic review"></div><div class="info_title_wrapper"><p class="slide_title info_title">The effect and cost-effectiveness of mass media campaigns on health behaviour change: A narrative systematic review</p><p class="slide_name"></p></div><div class="slide_body"><p>Mass media campaigns can reach a large number of people with health messages, but it is unclear how effective these are at changing health behaviours. We conducted a narrative review of systematic reviews to examine the impact of mass media campaigns on eight health behaviours, as well as their cost-effectiveness. Specifically, we explored the impact of mass media campaigns on tobacco use, dietary behaviours, alcohol use, physical activity, sun and UV-protection, HPV vaccination, cancer screening uptake, and symptomatic GP presentation. We concluded that mass media campaigns should be used as part of multi-component, community-based interventions and more research is needed to assess the cost-effectiveness of these types of campaign.</p>

<p><a href="/sites/default/files/mass_media_review_cruk_report.pdf">View the full report</a></p>
</div></div><div class="info_slide info_slide_68471"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_lung_x-ray_navy.png?itok=XIv-6-04" alt="Navy icon lung xray"></div><div class="info_title_wrapper"><p class="slide_title info_title">Cancer Research UK Lung Cancer screening project</p><p class="slide_name"></p></div><div class="slide_body"><p>This report presents the data from the 2022 Lung Cancer Screening survey, led by Cancer Research UK (CRUK), conducted by YouGov and with the costs of the project covered by ScottishPower.</p>

<p>This piece of research aims to inform CRUKs work in the lung cancer space. This may include taking action to support possible widespread introduction of targeted lung cancer screening by the NHS. It could also include work to mitigate any unintended consequences of targeted lung screening  such as impact on perceptions of the risk of lung cancer amongst people who have never smoked.</p>

<p>A bespoke survey was conducted to explore public perceptions around lung cancer and its risks, as well as knowledge and perceptions of screening, including eligibility and the impact of screening. This project built on previous work conducted by CRUK in order to optimise development of targeted lung cancer screening and ensure success of any future programme with minimised unintended consequences.</p>

<p><a href="/sites/default/files/cancer_research_uk_lung_screening_report.pdf">View the report</a></p>
</div></div><div class="info_slide info_slide_68481"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_ecigarette_grey_rgb_web_paint.png?itok=iOWqv8Jo" alt="E-cigarette icon"></div><div class="info_title_wrapper"><p class="slide_title info_title">Evaluation: e-cigarette relative harms pilot campaign 2018</p><p class="slide_name"></p></div><div class="slide_body"><p>An advertising campaign piloted by Cancer Research UK in 2018 aimed to promote quit attempts by increasing awareness of the relative harms of e-cigarettes compared with smoking. A cross-sectional survey evaluation was conducted surveying adults (16 years, n = 2217) living in the campaign region and the comparison/control regions. We tested interactions between time (pre, post) and region (campaign, control).</p>

<p>Compared with the control region, the campaign was associated with an increase in smokers motivation to quit but a smaller increase in adults perception of e-cigarettes as an effective cessation aid. It was identified that using mass media to communicate accurate information about the relative harms of e-cigarettes compared with smoking may be an effective strategy in increasing smokers motivation to quit. Further research is needed to evaluate effects on quit attempts and success.</p>

<p>Harry Tattan-Birch, Sarah E Jackson, Charlotte Ide, et al. <a href="https://academic.oup.com/ntr/advance-article/doi/10.1093/ntr/ntz236/5677516">Evaluation of the Impact of a Regional Educational Advertising Campaign on Harm Perceptions of E-Cigarettes, Prevalence of E-Cigarette Use, and Quit Attempts Among Smokers.</a> Nicotine Tob Res 2019. doi: 10.1093/ntr/ntz236</p>
</div></div><div class="info_slide info_slide_68486"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/standard_pack_0_0.png?itok=YC_cqch0" alt="Image of standard packaging on cigarette boxes"></div><div class="info_title_wrapper"><p class="slide_title info_title">Image of standard packaging on cigarette boxes</p><p class="slide_name"></p></div><div class="slide_body"><p>In the United Kingdom, standardised packaging for cigarettes was phased in between May 2016 and May 2017. A cross-sectional online survey was conducted with current smokers aged 16+ in two regions of England when both standardised and fully-branded packs were available. The study found that standardised packaging was associated with increased warning salience and thoughts about risks and quitting. Specifically, compared with never users, current users were more likely to have noticed the warnings on packs often/very often, read them closely often/very often, thought somewhat/a lot about the health risks of smoking and thought somewhat/a lot about quitting. These findings provided support for standardised packaging during the transition period.</p>

<p>Moodie C, Brose LS, Lee HS et al. <a href="https://www.tandfonline.com/doi/full/10.1080/16066359.2019.1579803">How did smokers respond to standardised cigarette packaging with new, larger health warnings in the United Kingdom during the transition period? A cross-sectional online survey</a>. Addiction Research &amp; Theory 2019.</p>
</div></div><div class="info_slide info_slide_68491"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/tc_gallery_0.png?itok=AzAdii6V" alt="Cancer awareness training evaluation"></div><div class="info_title_wrapper"><p class="slide_title info_title">Cancer awareness training evaluation</p><p class="slide_name"></p></div><div class="slide_body"><p>CRUK's training (Talk Cancer) aims to increase awareness of screening programmes and risk factors, promote more positive beliefs about cancer and increase confidence to discuss cancer with members of the public, among people working across the health service, local government, community and voluntary sectors who are appropriately placed to have these discussions with the public.</p>

<p>The evaluation found that the trainees' more positive beliefs about cancer, their increased confidence in discussing cancer and their increased awareness of bowel cancer screening were all maintained at 2 months.</p>

<p>Roberts A, Crook L, George H etc al. <a href="https://www.sciencedirect.com/science/article/pii/S2211335518301384?via%3Dihub">Two-month follow-up evaluation of a cancer awareness training workshop (Talk Cancer) on cancer awareness, beliefs and confidence of front-line public health staff and volunteers</a>. Prev Med Rep 2019.</p>
</div></div><div class="info_slide info_slide_68496"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/screening_hero.png?itok=pKfpCXnO" alt="Graphic showing pink test tube and screening device "></div><div class="info_title_wrapper"><p class="slide_title info_title">Exploring public views about delays in cancer screening</p><p class="slide_name"></p></div><div class="slide_body"><p>This report summarises the findings from an online survey (n=2,115), which contributes to discussions about the ethics of cancer screening in a pandemic situation. It aims to build an understanding of public attitudes towards cancer screening and any potential delays in cancer screening. The majority of participants (86%) wanted to know about any potential delays, and nearly half (48%) would prefer to experience a delay to their invitation over other parts of the screening pathway. The earlier in the pathway a delay is experienced the less anxiety participants anticipated.<a id="Diagnosis and Screening" name="Diagnosis%20and%20Screening"></a></p>

<p>This report supports a strategic delaying of cancer screening invitations under the proviso it ensures a shorter wait for follow-up tests and treatment. Ethical considerations about screening should include an emphasis on allowing the public to make an informed decision on their participation.</p>

<p><a href="/sites/default/files/cruk_screening_report_2021.pdf">View the report here</a></p>
</div></div><div class="info_slide info_slide_68501"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/magnifying_glass_icon_1.png?itok=Y4Q34qqa" alt="navy icon of magnifying glass"></div><div class="info_title_wrapper"><p class="slide_title info_title">Exploring public attitudes towards the new Faster Diagnosis Standard for cancer</p><p class="slide_name"></p></div><div class="slide_body"><p>An exploration into public attitudes towards the new Faster Diagnosis Standard for cancer, due to be introduced in England in 2020, within the context of a patients recent referral experiences.</p>

<p>It found that waiting for test results and responsibility for meeting the standard were the main concerns and it was concluded that patients should be asked what they would like to know about their referral and that GPs should be more transparent about the referral process and the potential for a lack of clarity around next steps.</p>

<p>Piano M, Black G, Amelung D et al. <a href="https://bjgp.org/content/early/2019/03/11/bjgp19X702677/tab-pdf">Exploring public attitudes towards the new Faster Diagnosis Standard for cancer: a focus group study with the UK public</a>. Br J Gen Pract 2019.</p>

<p>Want to generate bespoke preventable cancers stats statements? Download our<a href="/sites/default/files/interactive_statement_generator.xlsx">interactive statement generator.</a></p>
</div></div><div class="info_slide info_slide_68506"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/behaviour_change_0.png?itok=qFaijhWJ" alt="A theory and evidence-based redevelopment of a tool to support behaviour change"></div><div class="info_title_wrapper"><p class="slide_title info_title">A theory and evidence-based redevelopment of a tool to support behaviour change</p><p class="slide_name"></p></div><div class="slide_body"><p>Research shows that leading a healthy lifestyle can help prevent cancer. Further, diagnosing cancer at an early stage can increase survival rates. Cancer Research UK (CRUK)'s nurse-led outreach activity supports cancer prevention, early diagnosis and screening in deprived community settings. CRUK developed a habit-based behaviour change tool to support this activity and better enable conversations about behaviour change.</p>

<p><a href="/sites/default/files/evidence-based_redevelopment_of_a_tool_to_support_behaviour_change.pdf">View the report here</a></p>
</div></div><div class="info_slide info_slide_68511"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/policy_patient_data.png?itok=RQfPU5VL" alt="Navy icon of folder"></div><div class="info_title_wrapper"><p class="slide_title info_title">Cancer Research UKs Patient Survey 2021</p><p class="slide_name"></p></div><div class="slide_body"><p><span><span>Mass media campaigns can reach a large number of people with health messages, but it is unclear how effective these are at changing health behaviours. We conducted a narrative review of systematic reviews to examine the impact of mass media campaigns on eight health behaviours, as well as their cost-effectiveness. Specifically, we explored the impact of mass media campaigns on tobacco use, dietary behaviours, alcohol use, physical activity, sun and UV-protection, HPV vaccination, cancer screening uptake, and symptomatic GP presentation. We concluded that mass media campaigns should be used as part of multi-component, community-based interventions and more research is needed to assess the cost-effectiveness of these types of campaign.</span></span>This report summarises the key findings from the CRUK Patient Survey, which collected data from December 2020 to March 2021. Findings are from patients who share their stories and experiences and give an indication of the impact COVID-19 has had on their testing, treatment and care. New data on remote consultations and COVID-19 safety measures have been collected.</p>

<p>The barriers to timely cancer diagnosis and treatment identified by people affected by cancer in this report are not an entirely new phenomenon that have emerged only in the pandemic. Even before COVID-19, cancer services were on the verge of crisis, and the vast majority of patients surveyed supported governments taking steps required to make expanding capacity in cancer services a reality.</p>

<p><a href="/sites/default/files/cancer-stats/cruk_patient_survey/cruk_patient_survey_0.pdf">View the report here</a></p>
</div></div><div class="info_slide info_slide_73496"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/evaluating_the_impact_of_a_community-based_cancer_awareness_roadshow_on_awareness_attitudes_and_behaviors.jpg?itok=lRZCe0V3" alt="Evaluating the impact of a community-based cancer awareness roadshow on awareness, attitudes and behaviors"></div><div class="info_title_wrapper"><p class="slide_title info_title">Evaluating the impact of a community-based cancer awareness roadshow on awareness, attitudes and behaviors</p><p class="slide_name"></p></div><div class="slide_body"><p>Improving public awareness of cancer and encouraging health behavior change are important aspects of cancer control. We investigated whether a community-based roadshow was an effective way of communicating with the public about cancer and encouraging behavior change. Data were from 1196 people who completed questionnaires at a Cancer Research UK Cancer Awareness Roadshow in 2013. Of these, 511 (43%) completed questionnaires immediately before their visit (pre-visit group) and 685 (57%) completed questionnaires immediately after their visit (post-visit group). Among the post-visit sample, 217 (32%) were retained after two months. Self-reported data were available on risk factor and symptom awareness, help-seeking barriers, use of healthcare services and health behaviors. Compared with the pre-visit sample, the post-visit group had greater awareness of cancer risk factors and was more positive about aspects of help-seeking but awareness of potential symptoms was similar. Most effects were maintained over two months. Intentions to eat more fruit and vegetables and to exercise more were comparable between the groups but more people in the post-visit sample intended to quit smoking. At 2-month follow-up, smoking prevalence had significantly reduced but fruit and vegetable consumption decreased and there was no change to physical activity. User of weight loss services and general practitioner visits were high at follow-up and largely attributed to the Roadshow. The Cancer Research UK Roadshow appears to improve risk factor awareness, promote positive attitudes towards help-seeking and increase smoking cessation. This approach could be a useful building block for additional cancer prevention and control strategies.</p>

<p><a href="https://pubmed.ncbi.nlm.nih.gov/26921657/">View the full report</a></p>
</div></div><div class="info_slide info_slide_73501"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_ecigarette_grey_rgb_web_paint.png?itok=iOWqv8Jo" alt="E-cigarette icon"></div><div class="info_title_wrapper"><p class="slide_title info_title">What Drives Public Perceptions of E-cigarettes? </p><p class="slide_name"></p></div><div class="slide_body"><p>Despite growing evidence that e-cigarettes are less harmful than cigarettes, perceptions of equal or more harm have increased worldwide. This study aimed to identify the most common reasons behind peoples perceptions of the (i) relative harm of e-cigarettes compared with cigarettes and (ii) effectiveness of e-cigarettes for smoking cessation.</p>

<p><a href="https://www.sciencedirect.com/science/article/pii/S0376871623000443?via%3Dihub">View the full report here</a></p>
</div></div><div class="info_slide info_slide_73506"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/health_professional_primary_care.png?itok=9r0_24Ig" alt="navy icon of person with magnifying glass over them"></div><div class="info_title_wrapper"><p class="slide_title info_title">Cancer symptom experience and help-seeking behaviour during the COVID-19 pandemic in the UK</p><p class="slide_name"></p></div><div class="slide_body"><p id="p-3"><strong>Objectives</strong>To understand self-reported potential cancer symptom help-seeking behaviours and attitudes during the first 6 months (MarchAugust 2020) of the UK COVID-19 pandemic.</p>

<p id="p-4"><strong>Design</strong>UK population-based survey conducted during August and September 2020. Correlates of help-seeking behaviour were modelled using logistic regression in participants reporting potential cancer symptoms during the previous 6months. Qualitative telephone interviews with a purposeful subsample of participants, analysed thematically.</p>

<p><a href="https://bmjopen.bmj.com/content/11/9/e053095">Read the full report</a></p>
</div></div><div class="info_slide info_slide_73511"><div class="info_gallery_main_image info_image"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_stats_navy.png?itok=dNw_bpiM" alt="icon stats"></div><div class="info_title_wrapper"><p class="slide_title info_title">Intentions to participate in cervical and colorectal cancer screening during the COVID-19 pandemic</p><p class="slide_name"></p></div><div class="slide_body"><p>Worldwide, cancer screening faced significant disruption in 2020 due to the COVID-19<a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/pandemic" title="Learn more about pandemic from ScienceDirect's AI-generated Topic Pages">pandemic</a>. If this has led to changes in public attitudes towards screening and reduced intention to participate, there is a risk of long-term adverse impact on cancer outcomes. In this study, we examined previous participation and future intentions to take part in cervical and colorectal cancer (CRC) screening following the first national lockdown in the UK.</p>

<p><a href="https://www.sciencedirect.com/science/article/pii/S0091743521003959?via%3Dihub">Read the full report</a></p>
</div></div></div><div class="info_gallery_nav" id="info_gallery_nav_17"><ol class="info_links equal_height_links"><li id="info_gallery_link_" class="info_link info_gallery_link_74566"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/cruk_obesity_poster.jpg?itok=TGxhTdUu" alt=""></div><div class="link_bg"><p class="link_title">Obesity Campaign Evaluation</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_68516"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/mass-media-review-thumbnail.png?itok=-r_afk09" alt=""></div><div class="link_bg"><p class="link_title">The effect and cost-effectiveness of mass media campaigns on health behaviour change: A narrative systematic review</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_68471"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_lung_x-ray_navy.png?itok=XIv-6-04" alt=""></div><div class="link_bg"><p class="link_title">Cancer Research UK Lung Cancer screening project</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_68481"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_ecigarette_grey_rgb_web_paint.png?itok=iOWqv8Jo" alt=""></div><div class="link_bg"><p class="link_title">Evaluation: e-cigarette relative harms pilot campaign 2018</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_68486"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/standard_pack_0_0.png?itok=YC_cqch0" alt=""></div><div class="link_bg"><p class="link_title">Image of standard packaging on cigarette boxes</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_68491"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/tc_gallery_0.png?itok=AzAdii6V" alt=""></div><div class="link_bg"><p class="link_title">Cancer awareness training evaluation</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_68496"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/screening_hero.png?itok=pKfpCXnO" alt=""></div><div class="link_bg"><p class="link_title">Exploring public views about delays in cancer screening</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_68501"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/magnifying_glass_icon_1.png?itok=Y4Q34qqa" alt=""></div><div class="link_bg"><p class="link_title">Exploring public attitudes towards the new Faster Diagnosis Standard for cancer</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_68506"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/behaviour_change_0.png?itok=qFaijhWJ" alt=""></div><div class="link_bg"><p class="link_title">A theory and evidence-based redevelopment of a tool to support behaviour change</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_68511"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/policy_patient_data.png?itok=RQfPU5VL" alt=""></div><div class="link_bg"><p class="link_title">Cancer Research UKs Patient Survey 2021</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_73496"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/evaluating_the_impact_of_a_community-based_cancer_awareness_roadshow_on_awareness_attitudes_and_behaviors.jpg?itok=lRZCe0V3" alt=""></div><div class="link_bg"><p class="link_title">Evaluating the impact of a community-based cancer awareness roadshow on awareness, attitudes and behaviors</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_73501"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_ecigarette_grey_rgb_web_paint.png?itok=iOWqv8Jo" alt=""></div><div class="link_bg"><p class="link_title">What Drives Public Perceptions of E-cigarettes? </p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_73506"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/health_professional_primary_care.png?itok=9r0_24Ig" alt=""></div><div class="link_bg"><p class="link_title">Cancer symptom experience and help-seeking behaviour during the COVID-19 pandemic in the UK</p><p class="link_name"></p></div></a></li><li id="info_gallery_link_" class="info_link info_gallery_link_73511"><a href="#info_gallery_"><div class="info_img_wrapper"><img src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_members_gallery_large/public/icon_stats_navy.png?itok=dNw_bpiM" alt=""></div><div class="link_bg"><p class="link_title">Intentions to participate in cervical and colorectal cancer screening during the COVID-19 pandemic</p><p class="link_name"></p></div></a></li></ol></div></div></div>


</div>
<div class="panel-separator"></div>
<div class="panel-pane pane-fieldable-panels-pane pane-uuid-2c7132c1-a945-48f8-a36c-1b457148f892 pane-bundle-fieldable-panels-pane pane-promo">
  
      <h2 class="pane-title">
  Join us on X (previously known as Twitter)</h2>



<div class="pane-content">
  <div class="fieldable-panels-pane">
    

<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"> <table border="0" cellpadding="10" cellspacing="10">
<tr>
<td>
<h3>Join the conversation and follow @CRUKHCPs for news, updates and opinion.</h3>
</td>
<td>
<p><span class="button"><a href="https://twitter.com/crukhcps" target="_blank">@CRUKHCPs</a></span></p>
</td>
</tr>
</table>
 </div>
        </div>
</div>
</div>


</div>
<div class="panel-separator"></div><div class="panel-pane pane-fieldable-panels-pane pane-current-56391 pane-promo grey-panel">
  
        <h2 class="pane-title">See also</h2>
    
  
  <div class="pane-content">
    <div class="fieldable-panels-pane">
    

<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"> <p><a href="/health-professional/our-reports-and-publications/our-reports-and-publications-archived-reports">Earlier versions of recurrent reports and surveys may be found on our archived reports and publications page</a></p>
<p><a href="/about-us/we-develop-policy/policy-publications-and-research-tenders"><span>See all the publications from our policy teams and and current research tenders relevant to policy</span></a></p>
 </div>
        </div>
</div>
  </div>

  
  </div>
              </div>
        
        
        
        
      <div id="panel-22" class="col-md-12 col-sm-12 col-xs-12">
              </div>

        

</div>
  
            <div id="mobile-nav"></div>
     <!-- end of main content -->
    </main>

    
    
  </div><!-- #wrapper -->
</div>

<footer role="contentinfo">
  <div class="container">
    <div class="footer-links">
      <div class="footer-links__list">
        <h2>Speak to a nurse</h2>
        <ul>
          <li><a href="tel://0808%20800%204040">Nurse Helpline<br>0808 800 4040</a></li>
          <li>Questions about cancer? Call freephone<br>9 to 5 Monday to Friday or <a href="/about-us/contact-us/talk-to-our-nurses?secure=true">email us</a></li>
        </ul>
      </div>

      <div class="footer-links__list">
        <h2>Quick links</h2><ul class="links"><li class="0 first"><a href="/get-involved/find-a-shop">Find local shops</a></li>
<li class="1"><a href="https://shop.cancerresearchuk.org/?utm_source=cruk_footer">Shop online</a></li>
<li class="2"><a href="/about-us/contact-us">Contact us</a></li>
<li class="3 last"><a href="/about-us/charity-jobs">Jobs</a></li>
</ul>      </div>

      <div class="footer-links__icons">
        <h2>Follow us</h2>
        <ul>
          <li>
            <a href="https://www.facebook.com/cancerresearchuk/">
              <img src="/sites/all/themes/custom/cruk/images/social_icons/facebook_icon.svg" width="40" height="40" alt="Like Cancer Research UK on Facebook">
            </a>
          </li>
          <li>
            <a href="https://twitter.com/CR_UK">
              <img src="/sites/all/themes/custom/cruk/images/social_icons/twitter_icon.svg" width="40" height="40" alt="Follow Cancer Research UK on Twitter">
            </a>
          </li>
          <li>
            <a href="https://www.instagram.com/cr_uk/">
              <img src="/sites/all/themes/custom/cruk/images/social_icons/instagram_icon.svg" width="40" height="40" alt="Follow Cancer Research UK on Instagram">
            </a>
          </li>
          <li>
            <a href="https://www.linkedin.com/company/cancer-research-uk/">
              <img src="/sites/all/themes/custom/cruk/images/social_icons/linkedin_icon.svg" width="40" height="40" alt="Connect with Cancer Research UK on LinkedIn">
            </a>
          </li>
          <li>
            <a href="https://www.youtube.com/user/cancerresearchuk">
              <img src="/sites/all/themes/custom/cruk/images/social_icons/youtube_icon.svg" width="40" height="40" alt="Subscribe to Cancer Research UK on YouTube">
            </a>
          </li>
        </ul>
      </div>
    </div>

    <div class="footer-links">
      <div class="footer-links__list--horizontal">
        <ul class="links"><li class="0 first"><a href="/about-cancer/about-our-information">About our information</a></li>
<li class="1"><a href="/about-us/utilities/terms-and-conditions">Terms and conditions</a></li>
<li class="2"><a href="/about-us/utilities/privacy-statement">Privacy</a></li>
<li class="3"><a href="/modern-slavery-transparency-statement">Modern Slavery Statement</a></li>
<li class="4"><a href="/about-us/utilities/cookies-policy">Cookies</a></li>
<li class="5"><a href="/about-us/utilities/accessibility">Accessibility</a></li>
<li class="6 last"><a href="/sitemap">Sitemap</a></li>
</ul>      </div>
    </div>

    <div id="awards" class="footer-secondary-content">
      <a href="https://www.fundraisingregulator.org.uk/"><img src="/sites/all/themes/custom/cruk/images/fund-reg.svg" alt="Registered with Fundraising Regulator (logo)" width="165" height="52"></a>
    </div>

    <address class="footer-secondary-content">Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ.</address>
  </div>
</footer>
<script src="https://www.cancerresearchuk.org/sites/all/libraries/modernizr/modernizr-3.3.1.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/jquery/2.1/jquery.min.js?v=2.1.4"></script>
<script>jQuery.migrateMute=true;jQuery.migrateTrace=false;</script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/jquery-migrate/1/jquery-migrate.min.js?v=1"></script>
<script src="https://www.cancerresearchuk.org/misc/jquery-extend-3.4.0.js?v=2.1.4"></script>
<script src="https://www.cancerresearchuk.org/misc/jquery-html-prefilter-3.5.0-backport.js?v=2.1.4"></script>
<script src="https://www.cancerresearchuk.org/misc/jquery.once.js?v=1.2"></script>
<script src="https://www.cancerresearchuk.org/misc/drupal.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/ui/ui/minified/jquery.ui.core.min.js?v=1.10.2"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/ui/ui/minified/jquery.ui.widget.min.js?v=1.10.2"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/ui/external/jquery.cookie.js?v=67fb34f6a866c40d0570"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/ui/ui/minified/jquery.ui.position.min.js?v=1.10.2"></script>
<script src="https://www.cancerresearchuk.org/misc/ui/jquery.ui.position-1.13.0-backport.js?v=1.10.2"></script>
<script src="https://www.cancerresearchuk.org/misc/ajax.js?v=7.103"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/js/jquery_update.js?v=0.0.1"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/clientside_validation_rule_pword_match/js/clientside_validation_rule_pword_match.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_donate/js/cruk_donate.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_gc_timeline/js/jquery.kinetic.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_gc_timeline/js/timeline.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/entityreference/js/entityreference.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/geofield_gmap/geofield_gmap.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/resp_img/resp_img.js?" class="optanon-category-fun cruk-onetrust-blocked-scripts"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_core_info/js/cruk_core_info.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_core_info/js/clipboard.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_image_gallery/js/slick.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_shine_night_walks/js/select-styling.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_config_fieldable_panels/js/cruk_config_fieldable_panels_geolocation.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_donate/selectmenu/jquery.ui.selectmenu.js?v=1.3.0"></script>
<script src="https://www.cancerresearchuk.org/misc/progress.js?v=7.103"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_onetrust/js/crukOneTrustPlaceholder.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_onetrust/js/crukOneTrustDynatrace.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_onetrust/js/crukOneTrustRefreshBlockedScripts.js?"></script>
<script src="https://platform.twitter.com/widgets.js" class="optanon-category-tar cruk-onetrust-blocked-scripts"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_taxonomy_glossary/js/cruk_taxonomy_glossary.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/extlink/js/extlink.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/bootstrap/bootstrap/collapse.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/bootstrap/bootstrap/dropdown.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/bootstrap/bootstrap/transition.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/bootstrap/bootstrap/carousel.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/packery.pkgd.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/slick.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/pure.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/jquery.mobile.custom.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/media.match.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/enquire.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/ios-orientationchange-fix.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/console.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/tabs_to_accordion.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/cruk-accordion.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/jquery.megamenu.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/script.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/jquery.mobile-rebrand.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/interactive_timeline.js?"></script>
<script>jQuery.extend(Drupal.settings, {"basePath":"\/","pathPrefix":"","setHasJsCookie":0,"ajaxPageState":{"theme":"cruk","theme_token":"17sXWrXh50eGHmR6FOyfrV7dax4XKDVGG0DMKRL8fzY","jquery_version":"2.1","js":{"sites\/all\/modules\/custom\/cruk_image_gallery\/js\/cruk_image_gallery.js":1,"0":1,"sites\/all\/libraries\/modernizr\/modernizr-3.3.1.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/jquery\/2.1\/jquery.min.js":1,"1":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/jquery-migrate\/1\/jquery-migrate.min.js":1,"misc\/jquery-extend-3.4.0.js":1,"misc\/jquery-html-prefilter-3.5.0-backport.js":1,"misc\/jquery.once.js":1,"misc\/drupal.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.core.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.widget.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/external\/jquery.cookie.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.position.min.js":1,"misc\/ui\/jquery.ui.position-1.13.0-backport.js":1,"misc\/ajax.js":1,"sites\/all\/modules\/contrib\/jquery_update\/js\/jquery_update.js":1,"sites\/all\/modules\/custom\/clientside_validation_rule_pword_match\/js\/clientside_validation_rule_pword_match.js":1,"sites\/all\/modules\/custom\/cruk_donate\/js\/cruk_donate.js":1,"sites\/all\/modules\/custom\/cruk_gc_timeline\/js\/jquery.kinetic.min.js":1,"sites\/all\/modules\/custom\/cruk_gc_timeline\/js\/timeline.js":1,"sites\/all\/modules\/contrib\/entityreference\/js\/entityreference.js":1,"sites\/all\/modules\/contrib\/geofield_gmap\/geofield_gmap.js":1,"sites\/all\/modules\/contrib\/resp_img\/resp_img.js":1,"sites\/all\/modules\/custom\/cruk_core_info\/js\/cruk_core_info.js":1,"sites\/all\/modules\/custom\/cruk_core_info\/js\/clipboard.min.js":1,"sites\/all\/modules\/custom\/cruk_image_gallery\/js\/slick.min.js":1,"sites\/all\/modules\/custom\/cruk_shine_night_walks\/js\/select-styling.js":1,"sites\/all\/modules\/custom\/cruk_config_fieldable_panels\/js\/cruk_config_fieldable_panels_geolocation.js":1,"sites\/all\/modules\/custom\/cruk_donate\/selectmenu\/jquery.ui.selectmenu.js":1,"misc\/progress.js":1,"sites\/all\/modules\/custom\/cruk_onetrust\/js\/crukOneTrustPlaceholder.js":1,"sites\/all\/modules\/custom\/cruk_onetrust\/js\/crukOneTrustDynatrace.js":1,"sites\/all\/modules\/custom\/cruk_onetrust\/js\/crukOneTrustRefreshBlockedScripts.js":1,"https:\/\/platform.twitter.com\/widgets.js":1,"sites\/all\/modules\/custom\/cruk_taxonomy_glossary\/js\/cruk_taxonomy_glossary.js":1,"sites\/all\/modules\/contrib\/extlink\/js\/extlink.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/bootstrap\/bootstrap\/collapse.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/bootstrap\/bootstrap\/dropdown.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/bootstrap\/bootstrap\/transition.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/bootstrap\/bootstrap\/carousel.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/packery.pkgd.min.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/slick.min.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/pure.min.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/jquery.mobile.custom.min.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/media.match.min.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/enquire.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/ios-orientationchange-fix.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/console.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/tabs_to_accordion.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/cruk-accordion.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/jquery.megamenu.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/script.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/jquery.mobile-rebrand.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/interactive_timeline.js":1},"css":{"modules\/system\/system.base.css":1,"modules\/system\/system.menus.css":1,"modules\/system\/system.messages.css":1,"modules\/system\/system.theme.css":1,"0":1,"misc\/ui\/jquery.ui.core.css":1,"misc\/ui\/jquery.ui.theme.css":1,"modules\/aggregator\/aggregator.css":1,"sites\/all\/modules\/custom\/cruk_gc_timeline\/css\/grand_challenge_timeline.css":1,"modules\/field\/theme\/field.css":1,"sites\/all\/modules\/contrib\/geofield_gmap\/geofield_gmap.css":1,"modules\/node\/node.css":1,"modules\/search\/search.css":1,"modules\/user\/user.css":1,"sites\/all\/modules\/contrib\/extlink\/css\/extlink.css":1,"sites\/all\/modules\/contrib\/views\/css\/views.css":1,"sites\/all\/modules\/contrib\/ckeditor\/css\/ckeditor.css":1,"sites\/all\/modules\/contrib\/ctools\/css\/ctools.css":1,"sites\/all\/modules\/contrib\/panels\/css\/panels.css":1,"sites\/all\/themes\/custom\/cruk\/layouts\/100_333_73_landing_wide_multi_panels\/100_333_73_landing_wide_multi_panels.css":1,"sites\/all\/modules\/custom\/cruk_donate\/selectmenu\/jquery.ui.selectmenu.css":1,"sites\/all\/modules\/contrib\/node_embed\/plugins\/node_embed\/node_embed.css":1,"sites\/all\/modules\/custom\/cruk_taxonomy_glossary\/css\/cruk_taxonomy_glossary.css":1,"sites\/all\/themes\/contrib\/mothership\/mothership\/css\/reset.css":1,"sites\/all\/themes\/contrib\/mothership\/mothership\/css\/reset-html5.css":1,"sites\/all\/themes\/contrib\/mothership\/mothership\/css\/mothership-default.css":1,"sites\/all\/themes\/contrib\/mothership\/mothership\/css\/mothership.css":1,"sites\/all\/themes\/custom\/cruk\/css\/tabs_to_accordion.css":1,"sites\/all\/themes\/custom\/cruk\/css\/style.css":1,"sites\/all\/themes\/custom\/cruk\/css\/cruk.menus.css":1,"sites\/all\/themes\/custom\/cruk\/css\/mobile.menu.css":1,"sites\/all\/themes\/custom\/cruk\/css\/slick.css":1,"sites\/all\/themes\/custom\/cruk\/css\/content_panel.css":1,"sites\/all\/themes\/custom\/cruk\/css\/scroller.css":1,"sites\/all\/themes\/custom\/cruk\/normalize.css":1,"sites\/all\/themes\/custom\/cruk\/reset.css":1,"sites\/all\/themes\/custom\/cruk\/reset-html5.css":1,"sites\/all\/themes\/custom\/cruk\/mothership.css":1,"sites\/all\/themes\/custom\/cruk\/mothership-default.css":1,"sites\/all\/themes\/custom\/cruk\/mothership-devel-mediaqueries.css":1,"sites\/all\/themes\/custom\/cruk\/css\/print.css":1,"public:\/\/ctools\/css\/d8941fb35cec075cfcb80998f82e95c3.css":1,"public:\/\/css_injector\/css_injector_31.css":1,"public:\/\/css_injector\/css_injector_131.css":1,"public:\/\/css_injector\/css_injector_156.css":1,"public:\/\/css_injector\/css_injector_196.css":1,"public:\/\/css_injector\/css_injector_201.css":1,"public:\/\/css_injector\/css_injector_206.css":1,"public:\/\/css_injector\/css_injector_211.css":1,"public:\/\/css_injector\/css_injector_226.css":1,"public:\/\/css_injector\/css_injector_241.css":1,"public:\/\/css_injector\/css_injector_251.css":1,"public:\/\/css_injector\/css_injector_261.css":1,"public:\/\/css_injector\/css_injector_276.css":1,"public:\/\/css_injector\/css_injector_281.css":1,"public:\/\/css_injector\/css_injector_291.css":1,"public:\/\/css_injector\/css_injector_296.css":1,"public:\/\/css_injector\/css_injector_306.css":1,"public:\/\/css_injector\/css_injector_361.css":1,"public:\/\/css_injector\/css_injector_371.css":1,"public:\/\/css_injector\/css_injector_376.css":1,"public:\/\/css_injector\/css_injector_426.css":1,"public:\/\/css_injector\/css_injector_441.css":1,"public:\/\/css_injector\/css_injector_456.css":1,"public:\/\/css_injector\/css_injector_466.css":1,"public:\/\/css_injector\/css_injector_471.css":1,"public:\/\/css_injector\/css_injector_516.css":1,"public:\/\/css_injector\/css_injector_561.css":1,"public:\/\/css_injector\/css_injector_576.css":1,"public:\/\/css_injector\/css_injector_581.css":1,"public:\/\/css_injector\/css_injector_610.css":1,"public:\/\/css_injector\/css_injector_616.css":1,"public:\/\/css_injector\/css_injector_617.css":1,"public:\/\/css_injector\/css_injector_619.css":1,"public:\/\/css_injector\/css_injector_620.css":1}},"respImg":{"default_suffix":"_breakpoint_one","current_suffix":false,"forceRedirect":"0","forceResize":"1","reloadOnResize":"0","useDevicePixelRatio":1,"suffixes":{"_breakpoint_two":640,"_breakpoint_three":480,"_breakpoint_four":320,"_breakpoint_one":1}},"cruk_info_galleries":{"info-gallery-id-3":{"gallery_id":3,"info_nav_arrows_setting_desktop":"false","info_nav_arrows_setting_tablet":"false","info_nav_arrows_setting_mobile":"false","info_nav_dots_setting_desktop":"false","info_nav_dots_setting_tablet":"false","info_nav_dots_setting_mobile":"false","info_nav_btns_num_setting_desktop":"5","info_nav_btns_num_setting_tablet":"3","info_nav_btns_num_setting_mobile":null},"info-gallery-id-5":{"gallery_id":5,"info_nav_arrows_setting_desktop":"false","info_nav_arrows_setting_tablet":"false","info_nav_arrows_setting_mobile":"false","info_nav_dots_setting_desktop":"false","info_nav_dots_setting_tablet":"false","info_nav_dots_setting_mobile":"false","info_nav_btns_num_setting_desktop":"5","info_nav_btns_num_setting_tablet":"3","info_nav_btns_num_setting_mobile":null},"info-gallery-id-7":{"gallery_id":7,"info_nav_arrows_setting_desktop":"false","info_nav_arrows_setting_tablet":"true","info_nav_arrows_setting_mobile":"true","info_nav_dots_setting_desktop":"false","info_nav_dots_setting_tablet":"false","info_nav_dots_setting_mobile":"false","info_nav_btns_num_setting_desktop":"5","info_nav_btns_num_setting_tablet":"3","info_nav_btns_num_setting_mobile":null},"info-gallery-id-9":{"gallery_id":9,"info_nav_arrows_setting_desktop":"false","info_nav_arrows_setting_tablet":"true","info_nav_arrows_setting_mobile":"true","info_nav_dots_setting_desktop":"false","info_nav_dots_setting_tablet":"false","info_nav_dots_setting_mobile":"false","info_nav_btns_num_setting_desktop":"5","info_nav_btns_num_setting_tablet":"3","info_nav_btns_num_setting_mobile":null},"info-gallery-id-11":{"gallery_id":11,"info_nav_arrows_setting_desktop":"false","info_nav_arrows_setting_tablet":"true","info_nav_arrows_setting_mobile":"true","info_nav_dots_setting_desktop":"false","info_nav_dots_setting_tablet":"false","info_nav_dots_setting_mobile":"false","info_nav_btns_num_setting_desktop":"5","info_nav_btns_num_setting_tablet":"3","info_nav_btns_num_setting_mobile":null},"info-gallery-id-13":{"gallery_id":13,"info_nav_arrows_setting_desktop":"false","info_nav_arrows_setting_tablet":"true","info_nav_arrows_setting_mobile":"true","info_nav_dots_setting_desktop":"false","info_nav_dots_setting_tablet":"false","info_nav_dots_setting_mobile":"false","info_nav_btns_num_setting_desktop":"5","info_nav_btns_num_setting_tablet":"3","info_nav_btns_num_setting_mobile":null},"info-gallery-id-15":{"gallery_id":15,"info_nav_arrows_setting_desktop":"false","info_nav_arrows_setting_tablet":"true","info_nav_arrows_setting_mobile":"true","info_nav_dots_setting_desktop":"false","info_nav_dots_setting_tablet":"false","info_nav_dots_setting_mobile":"false","info_nav_btns_num_setting_desktop":"5","info_nav_btns_num_setting_tablet":"3","info_nav_btns_num_setting_mobile":null},"info-gallery-id-17":{"gallery_id":17,"info_nav_arrows_setting_desktop":"false","info_nav_arrows_setting_tablet":"true","info_nav_arrows_setting_mobile":"true","info_nav_dots_setting_desktop":"false","info_nav_dots_setting_tablet":"false","info_nav_dots_setting_mobile":"false","info_nav_btns_num_setting_desktop":"5","info_nav_btns_num_setting_tablet":"3","info_nav_btns_num_setting_mobile":null},"info-gallery-id-21":{"gallery_id":21,"info_nav_arrows_setting_desktop":"false","info_nav_arrows_setting_tablet":"true","info_nav_arrows_setting_mobile":"true","info_nav_dots_setting_desktop":"false","info_nav_dots_setting_tablet":"false","info_nav_dots_setting_mobile":"false","info_nav_btns_num_setting_desktop":"5","info_nav_btns_num_setting_tablet":"3","info_nav_btns_num_setting_mobile":null}},"extlink":{"extTarget":"_blank","extClass":"external","extLabel":"(link is external)","extImgClass":0,"extIconPlacement":0,"extSubdomains":1,"extExclude":"(twitter\\.com|facebook\\.com|addthis\\.com|cancerresearchuk\\.org|cruk\\.org|cruk01)","extInclude":"https:\/\/www.cancerresearchuk.org\/(sites\/default\/files\/*)","extCssExclude":".social-link,.ignore-external,.navbar,.cruk-nav,.footer-social,.about-cancer-footer-icons,.pane-node-field-landing-key-message","extCssExplicit":"","extAlert":0,"extAlertText":"This link will take you to an external web site.","mailtoClass":0,"mailtoLabel":"(link sends e-mail)","extUseFontAwesome":0}});</script>

      
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_image_gallery/js/cruk_image_gallery.js?"></script>
<script>
  function OptanonWrapper() {

    crukOneTrustUpdatePlaceholders();

    crukOneTrustUpdateDynatrace();

    crukOneTrustRefreshBlockedScripts();
}</script>
</body>
</html>
